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Chapter 1
Over the past two centuries, global human life expectancy at birth has risen to 
72.0 years in 2016 (1) and even to 80.8 years in high-income countries (2) following 
the implementation of hygiene, continuous advancements in health care, and 
improved access to better nutrition. Simultaneously, the proportion of older 
adults aged over 65 is progressively growing as a consequence of the increase 
in life expectancy; in 2019, 9.1% of the global population was over the age of 
65, and this is envisioned to rise to 15.9% in 2050, and 22.6% by 2100 (3). This 
phenomenon is exaggerated in high-income countries such as the Netherlands, 
with 19.2% of the population over the age of 65 in 2019, which is projected to 
surpass 25% as soon as 2040 (4). With advanced age, however, quality of life is 
also impacted and susceptible to decline. There is an increased risk of morbidity 
with advanced age stemming from noncommunicable diseases such as type 2 
diabetes mellitus (T2DM), cardio-vascular disease (CVD), malignancies, and 
degenerative diseases (5), which are dominantly represented amongst the leading 
causes of mortality in high-income countries (6). Together, the increase in life 
expectancy, the change in demographic composition, and the chronic nature of 
noncommunicable disease are driving the increasing socio-economic burden 
of disease, with the Netherlands projected to face an annual increase of 2.8% in 
health care expenditure until 2040 (7), thus warranting a switch in focus from 
improving lifespan to improving healthspan.
The challenge of ageing is not just a matter of time
The rate of ageing is unique to an individual and thus age should be separated in 
two forms; one being chronological age, the other biological age. Chronological 
ageing is purely subject to the passing of time and cannot be influenced as 
such. Contrastingly, an individual’s biological ageing is more fluid and can be 
accelerated or slowed depending on factors such as genetic background, lifestyle 
and nutrition, socio-economic status, and environmental influences such as 
health care (8, 9). The biological processes involved in ageing are complex and 
are predominantly driven by stochastic damage acquired by cells and tissues 
over time (10), thereby defining ageing as the time-dependent decline of function 
through the loss of physiological integrity (5).
Nine hallmarks of ageing were defined in order to provide structure to the 
research effort pursuing the prolongation of human healthspan (5). These 
Niels_Proefschrift.indd   8 08/12/2020   18:04:19
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nine hallmarks of ageing can be divided into three categories: 1) the primary 
hallmarks that cause damage to cells and tissues, being genomic instability, 
telomere attrition, epigenetic alterations, and the loss of proteostasis; 2) the 
antagonistic hallmarks responding to the damage done, being deregulated 
nutrient sensing, mitochondrial dysfunction, and cellular senescence; and 3) 
the integrative hallmarks which are the net result of the previous categories and 
ultimately lead to the functional decline of ageing, being exhaustion of stem cells 
and alterations in intercellular communication (5).
Thesis aim
In this thesis, the main focus lies with targeting two of the antagonistic hallmarks 
of ageing, i.e. mitochondrial dysfunction and deregulated nutrient sensing, 
which exude beneficial effects when present in low levels, but at higher levels 
become deleterious. By targeting these two antagonistic hallmarks of ageing, this 
thesis aims to identify and investigate novel targets to promote healthy ageing 
by improving metabolic health.
Deregulated nutrient sensing and mitochondrial dysfunction 
are intertwined
Mitochondria are vital and highly dynamic organelles involved in cellular 
metabolism and responsible for the reduction of nicotinamide dinucleotide 
(NAD+) to NADH and flavin adenine dinucleotide (FAD) to FADH2 from 
catabolism of monosaccharides, lipids, and ketogenic and amino acids in the 
tricarboxic acid cycle (TCA cycle). Subsequently, NADH and FADH2 are oxidized 
and the electrons released are donated to the electron transport chain (ETC) in 
the process of aerobic production of adenosine triphosphate (ATP), the energy 
currency of the cell.
Nutrient sensing in cellular metabolism
The sirtuin (SIRT) enzyme family is involved in the regulation of cellular 
metabolism and comprises of a group of seven NAD+-dependent deacetylases 
with specific compartmentalization within cells and tissues (11), of which 
SIRT1 and SIRT3 are the most prominently studied due to their putative role in 
extending longevity through caloric restriction, the combat of age-dependent 
1
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disease, and control of metabolic homeostasis (12). SIRT1 resides in the nucleus 
and cytosol of the cell and orchestrates, among others, mitochondrial biogenesis 
through deacetylation of peroxisome proliferator-activated receptor gamma 
coactivator-1-alpha (PGC-1α) and controls glucose and lipid metabolism 
following deacetylation of forkhead box protein O1 (FOXO1). SIRT3 is located 
in the mitochondria and acts as the main mitochondrial deacetylase and 
controlling metabolic homeostasis and the stress response to reactive oxygen 
species (ROS) (12). Notably, SIRT1 is a downstream target of AMP-activated 
protein kinase (AMPK) activation, which reflects the energy status of the cell 
based on the adenosine monophosphate (AMP) and adenosine diphosphate 
(ADP) levels relative to ATP levels (13). Activation of AMPK leads to induction 
of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme 
in NAD+ synthesis from nicotinamide (NAM), thereby facilitating activation of 
SIRT1, which is sensitive to the NAD+/NADH redox potential (14). Additionally, 
SIRT1 and AMPK can enforce a positive feedback loop to coordinate a unified 
response to low energetic states (15). Together, AMPK and SIRT1 are thought of 
as nutrient sensors, sensitive to a low-energy status of the cell and catabolism (13, 
16), with downstream targets beneficial to overall metabolic health (Figure 1) (5). 
With NAD+ levels (17, 18) and mitochondrial function (19) known to decline with 
age, NAD+-supplementation through dietary intervention has been proposed as 
a potential effective strategy to improve mitochondrial function and metabolic 
health, and is the focus of Chapters 2 and 3.
Niels_Proefschrift.indd   10 08/12/2020   18:04:19
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Figure 1 – Schematic overview of the connection between nutrient sensors AMPK and 
SIRT and mitochondrial function. Abbreviations: AMP = adenosine monophosphate, 
AMPK = AMP-activated protein kinase, ATP = adenosine triphosphate, FOXO1 = forkhead 
box protein O1, PGC-1α = peroxisome proliferator-activated receptor gamma coactivator-
1-alpha, NAD(H) = nicotinamide adenine dinucleotide, SIRT1 = sirtuin 1.
The missing link between mitochondrial dysfunction and skeletal muscle 
health
With such a pivotal role in metabolism it is unsurprising that mitochondria 
have been implicated in the development of age-related disease and frailty (5, 
10, 20), with frailty comprising unintentional weight loss, dynapenia, fatigue, 
poor mobility, and an inactive lifestyle (21). Skeletal muscle is the most abundant 
metabolically active tissue in the human body and is essential to maintaining 
metabolic health (22, 23). Moreover, body composition changes under the 
influence of ageing, with skeletal muscle mass declining (24, 25) and abdominal 
adiposity increasing (25, 26), which accelerates the age-dependent decline in 
physical function, and ultimately comprises independence (27). Collectively, the 
age-related loss of skeletal muscle mass, strength, and physical functionality is 
referred to as sarcopenia (28) and thus, is closely related to the frailty phenotype 
(23). The development of sarcopenia can be accelerated under the influence 
of nutritional deficiencies, lack of physical activity, metabolic disturbance, 
and comorbidities (29), which are paralleled by an age-dependent decline in 
mitochondrial function (19). To which extent skeletal muscle mitochondrial 
function, skeletal muscle health, and physical function relate to one another is 
1
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the subject of Chapter 4, aiming to increase our understanding of muscle health 
in order to identify novel targets for future interventions to counteract the onset 
of sarcopenia and frailty.
Time is of the essence
Various metabolic processes in the human body, such as energy expenditure and 
glucose homeostasis, are known to adhere to a day-night rhythm (30, 31), and it 
has become increasingly clear that these rhythms are governed by the molecular 
clock (32). The molecular clock resides in each cell and is synchronized to the 
master clock located in the suprachiasmatic nucleus (SCN), which uses sunlight 
and other Zeitgebers (“time givers”) like physical activity and food consumption 
as synchronizers to the world around us (33). The intricate inner workings of 
the molecular clock comprise an interplay of negative feedback loops creating 
an oscillating rhythm in gene transcription spanning approximately 24 hours. 
Briefly, the positive regulators circadian locomotor output cycles kaput (CLOCK) 
and brain and muscle Arnt-like 1 (BMAL1) form a heterodimer and bind to 
the enhancer box (E-box) complex in the nucleus in order to transcribe their 
own negative regulators, period circadian protein (PER) and cryptochrome 
(CRY), which in turn heterodimerize, relocate to the nucleus, and inhibit the 
transcription mediated by the CLOCK:BMAL1 complex (depicted in Figure 2) 
(32).
With SIRT1 known to affect CLOCK:BMAL1-mediated transcription through 
NAD+ availability (34, 35), a natural progression was to consider the influence 
of the molecular clock on mitochondrial function, with BMAL1 shown to induce 
NAMPT expression leading to NAD+ production, and ultimately, SIRT3 activation 
(36), thereby creating an additional enzymatic negative feedback loop to the 
molecular clock mechanism (32). Similarly, AMPK is directly involved in the 
phosphorylation and degradation of CRY and thus contributes to the regulation 
of the potency of the transcription negative feedback loop (Figure 2) (32).
Niels_Proefschrift.indd   12 08/12/2020   18:04:22
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Figure 2 – Overview of the transcription and enzymatic feedback loops connecting 
the molecular clock to cellular metabolism. Abbreviations: AMPK = AMP-activated 
protein kinase, BMAL1 = brain and muscle Arnt-like 1, CLOCK = circadian locomotor 
output cycles kaput, Cry = cryptochrome, E-box = enhancer box, Per = period circadian 
protein, NAD(H) = nicotinamide adenine dinucleotide, NAM = nicotinamide, 
NAMPT = nicotinamide phosphoribosyltransferase, SIRT1 = sirtuin 1.
Adapted from: Eckel-Mahan et al. Metabolism and the Circadian Clock Converge. 
Physiological Reviews. 2013.
Recently, mitochondrial function has been demonstrated to exhibit a rhythmic 
day-night cycle in young, healthy, lean men (37), thereby confirming the link 
between the molecular clock and mitochondrial function. With mitochondrial 
function known to be impaired in older adults (19) and insulin resistant 
individuals (38, 39), the question raised is whether an impaired mitochondrial 
function also translates into an impairment in molecular clock functionality, 
which is investigated in Chapter 5, thereby possibly revealing a novel target for 
the combat of mitochondrial dysfunction in ageing and insulin resistance.
The obesity pandemic: tipping the scales in the wrong direction
The prevailing obesity pandemic constitutes a major risk for the development of 
noncommunicable diseases (40), and as of 2016, 38.9% of all adults globally were 
overweight (body mass index (BMI) >25 kg/m2) (41) and 13.1% were obese (BMI 
>30 kg/m2) (42). Unfortunately, these numbers are still on the rise, in part by the 
aggravation of the development of obesity seen with ageing, thereby adding 
more weight to the socio-economic burden of disease.
In essence, obesity is the consequence of a chronic state of energy abundance as 
a result of energy consumption outweighing energy expenditure. Thus, a great 
1
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deal of research has been devoted to identifying and developing strategies that 
can ensure sustainable and long-term weight loss, an outcome that has been 
frustratingly difficult to achieve. The two main strategies employed to instate a 
negative energy balance are 1) decreasing energy intake and 2) increasing energy 
expenditure. Caloric restriction has seen many forms and shapes throughout 
time, but ultimately, the effects are aimed at reducing overall body weight by 
decreasing energy intake, and on a molecular level, activating AMPK and its 
downstream target SIRT1. Daily energy expenditure (EE) is the sum of three 
components; i.e. basal metabolic rate (BMR), diet-induced thermogenesis (DIT), 
and physical activity (43). The BMR is primarily determined by skeletal muscle 
mass (44) and accounts for up to 75% of daily EE, whereas DIT constitutes up 
to 15% of daily EE through the post-prandial increase in EE due to digestion, 
absorption, and storage of food (45). The remaining 10% of daily EE is accounted 
for by physical activity, which can be increased or decreased voluntarily. 
Increasing energy expenditure through physical activity has been a staple in 
the combat of obesity, however, there are other means that can contribute to 
increasing energy expenditure.
Adaptive (non-shivering) thermogenesis is the dissipation of energy as heat in 
response to cold exposure (cold-induced thermogenesis) or high-energy intake 
(diet-induced thermogenesis) and originates from beige and brown adipose 
tissue (BAT). Following the ‘rediscovery’ of functional BAT depots in humans 
(46-48), the increase in energy expenditure due to acute cold exposure (49, 50) 
and the thermogenic effect of a high-calorie meal (51) have been attributed to 
BAT activation. Hence, increasing daily EE through BAT-mediated DIT could be 
an effective strategy to combat obesity in humans. Notably, BAT abundance is 
subjected to decline with increasing age (52) and BMI (46), further exacerbating 
the development of metabolic disease and obesity (53). Fortunately, a thermogenic 
mechanism was recently revealed in murine beige adipocytes involving a 
creatine-driven substrate cycle (54) leading to the hypothesis that creatine 
abundance may contribute to overall energy balance in humans by increasing 
DIT and BAT activation, which is investigated in Chapter 6.




This thesis aims to identify and investigate novel targets with the aim to promote 
healthspan by improving metabolic health. Encompassing a narrative review, 
two cross-sectional studies, and two intervention trials, this thesis focusses 
on a number of targets aiming to combat metabolic disease stemming from 
mitochondrial dysfunction and dysregulated nutrient sensing as seen in ageing, 
obesity, and insulin resistance (depicted in Figure 3).
Figure 3 – An overview of the contents of this thesis. The numbers denote the chapters 
with each major topic.
In Chapter 2, the state-of-the-art concerning the efficacy of influencing the NAD+ 
metabolism in humans is reviewed with the aim to identify strategies to improve 
metabolic health. Chapter 3 takes inspiration from the preceding chapter 
and investigates the efficacy of a dietary approach to NAD+ supplementation 
on skeletal muscle mitochondrial function in fourteen community-dwelling, 
physically compromised, older adults in a randomised, controlled trial. Chapter 
4 investigates the relationship between skeletal muscle mitochondrial function 
and its respective relationship with skeletal muscle health and physical function 
in the presence of ageing. These relationships are studied through detailed 
metabolic phenotyping of 59 individuals including older adults with a range 
in physical function, varying from frail to athletes, and healthy, young adult 
controls. Chapter 5 investigates the rhythmicity of skeletal muscle mitochondrial 
function in a group of twelve overweight, middle-aged to older, insulin resistant 
men though serial skeletal muscle biopsies under strictly controlled living 
conditions. In Chapter 6, the role of creatine abundance on brown adipose tissue 
1
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activation and diet-induced thermogenesis is investigated in fourteen healthy, 
vegetarian adults in a randomised, placebo-controlled trial.
In conclusion, Chapter 7 will reflect on the major findings of the preceding 
experimental chapters in this thesis and discuss their relevance and impact in the 
broader perspective of the scientific status quo, culminating in recommendations 
for future research in the field of ageing and metabolic research.
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Abstract
NAD+ has gone in and out of fashion within the scientific community a number 
of times since its discovery in the early 1900s. Over the last decade, NAD+ has 
emerged as a potential target for combatting metabolic disturbances and the 
mitochondrial dysfunction that is mediated through sirtuin (SIRT) enzymes. The 
beneficial metabolic effects of the NAD+/SIRT axis have triggered an increased 
interest in NAD+ as an enhancer of energy metabolism. As a result, a myriad of 
publications have focused on NAD+ metabolism, with the majority of the work 
having been performed using in vitro models, and in vivo work largely consisting 
of interventions in Caenorhabditis elegans and rodents. Human intervention trials, 
on the other hand, are scarce. The aim of this review is to provide an overview 
of the state-of-the-art on influencing NAD+ metabolism in humans and to set the 
stage for what the future of this exciting field may hold.
Keywords Diabetes, Energy metabolism, Human, Metabolic disease, NAD+, 
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In recent years, a tremendous effort has been made to identify approaches for 
combatting metabolic disturbances and mitochondrial dysfunction, such as those 
seen in ageing [1] and type 2 diabetes mellitus [2, 3] by specifically targeting 
the sirtuin (SIRT) enzyme family [4]. SIRTs are NAD+-dependent deacetylating 
enzymes that regulate cellular metabolism [5]. To date, seven mammalian SIRT 
enzymes (SIRT1–7) have been identified, each having its own characteristic tissue 
and subcellular compartment expression, enzyme activity and targets. We kindly 
refer readers to Houtkooper et al [6] for a comprehensive review on SIRTs.
Several SIRT-targeting strategies have been deployed, demonstrating the metabolic 
benefits of SIRT activation. In mice, a SIRT1 gain-of-function mutation evoked a 
metabolic profile that protected against insulin-resistant diabetes by increasing hepatic 
insulin sensitivity, hepatic glucose tolerance and overall metabolic efficiency [7, 8]. 
Moreover, a proposed SIRT1 activator, SRT1720, increased mitochondrial respiration 
and improved insulin sensitivity [9], mimicking the signalling profile observed with 
caloric restriction [10] in high-fat-diet (HFD)-challenged mice. Resveratrol, an AMP-
activated protein kinase (AMPK)-activating polyphenol that activates SIRT1, improved 
skeletal muscle mitochondrial function in healthy obese men, in individuals with 
type 2 diabetes and in first-degree relatives of those with type 2 diabetes, although 
the observed metabolic health effects are inconsistent [11, 12]. Together, these studies 
indicate that SIRT activation promotes metabolic health.
Why NAD+?
The concept of influencing NAD+ bioavailability to activate the SIRTs was 
recently proposed for combatting metabolic disturbances and mitochondrial 
dysfunction in humans [13, 14]. This is supported by reports that decreased NAD 
bioavailability contributes to metabolic disturbances in ageing mice [15, 16] and 
humans [17, 18], and also in a rodent model of type 2 diabetes mellitus [16]. SIRTs 
are important consumers of NAD+ and depend on this rate-limiting substrate to 
act as metabolic sensors, responding to the level of available NAD+.
Considering the limited scope of this review, we will not digress into detail of 
the NAD+ metabolism and refer the reader to more comprehensive reviews on 
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this topic [5, 19-21]. Briefly, however, as NADH is the predominant electron donor 
to the electron transport chain, NADH/NAD+ redox potential is an important 
indicator of the bioenergetic status of the cell and is tightly regulated [21]. The 
cytosolic and mitochondrial NADH/NAD+ and NADPH/NADP+ redox states 
are strongly connected. These states depend on the formation of NAD+ from 
NADH through cellular processes, such as the glycolytic enzyme activity, the 
citric acid cycle and the electron transport chain [20], thereby exemplifying the 
essentiality of NAD+ and its redox potential within cellular metabolism. The 
NAD+ pool is maintained through a continuous process of biosynthesis and 
breakdown, stemming from the salvage and the Preiss–Handler pathways or 
from de novo biosynthesis at one end, and enzymatic consumption at the other 
[20] (Fig. 1). When NAD+ levels rise, SIRTs activate and deac(et)ylate or mono-
ADP-ribosylate a variety of metabolic substrates, such as peroxisome proliferator-
activated receptor gamma coactivator 1α (PGC-1α) and forkhead box protein O1 
(FOXO1). This elicits an array of metabolic adaptations, including mitochondrial 
biogenesis in skeletal muscle [19] and enhanced oxidative metabolism in skeletal 
muscle, brown adipose tissue and the liver [22, 23]. On a physiological level, this 
may lead to improved insulin sensitivity [24, 25], improved metabolic flexibility 
[26] and increased mitochondrial function [26, 27].
Figure 1 – Summary of NAD+ metabolism. NAD+ can be synthesised from Trp through the 
de novo biosynthesis pathway in the liver and kidneys. Nicotinic acid (more commonly 
known as vitamin B3) enters the NAD+ pool through the Preiss–Handler pathway, 
whereas nicotinamide, nicotinamide riboside and NMN (re-)enter the NAD+ pool through 
the salvage pathway. NAD+ is consumed by SIRTs, CD38, and PARP enzymes, producing 
nicotinamide, which enters the pool of NAD+ precursors for resynthesis into NAD+. 
Dashed arrow, movement of NAD+ within the NAD+ pool. NA, nicotinic acid; NAAD, 
nicotinic acid adenine dinucleotide; NAM, nicotinamide; NR, nicotinamide riboside.
2
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NAD+ boosting strategies: preclinical evidence
Exercise and caloric restriction induce nicotinamide 
phosphoribosyltransferase expression through AMPK
Exercise and caloric restriction share a common denominator in that they affect 
AMPK activity, which can modulate NAD+ bioavailability (Fig. 2). To support 
this, AMPK activation in C2C12 myotubes increases cellular NAD+ levels and, 
in turn, activates SIRT1 and the subsequent PGC-1α-dependent upregulation of 
mitochondrial and lipid metabolism [28]. An increased demand for energy by the 
cell, such as during exercise, activates AMPK. With this in mind, it was shown 
that exercise induces the expression of nicotinamide phosphoribosyltransferase 
(NAMPT), the rate-limiting enzyme that converts nicotinamide into NAD+ [29], 
thereby increasing NAD+ bioavailability [30, 31]. The induction of NAMPT 
expression through AMPK has been suggested to be a mechanistic adaptation 
to the metabolic stress derived from both exercise and caloric restriction [32-34]. 
Moreover, exercise in rats has been demonstrated to induce de novo biosynthesis 
of NAD+ from l-tryptophan (Trp), ultimately increasing NAD+ bioavailability 
[35].
Figure 2 – Effect of activating the NAD+/SIRT axis by increasing NAD+ bioavailability. 
Several approaches may be used to increase NAD+ bioavailability, including exercise, 
caloric restriction, dietary supplementation and inhibition of NAD+ consumption. These 
changes positively affect SIRT activation and subsequent PGC-1α and FOXO1 expression, 
resulting in mitochondrial changes and, as a consequence, metabolic adaptations. CD38i, 
CD38 inhibitor; FOXO1, forkhead box protein O1; NAM, nicotinamide; PARPi, PARP 
inhibitor. This figure was produced using Servier Medical Art, available from smart.
servier.com, licensed under a Creative Commons Attribution 3.0 Unported License 
(https://creativecommons.org/licenses/by/3.0/).
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NAD+ precursors increase NAD+ bioavailability and activate SIRTs
Various research groups have pursued sustained SIRT activation through an 
increase in endogenous NAD+ bioavailability. Preclinical research in ageing or 
HFD-challenged mice has shown that boosting NAD+ levels by supplementation 
with NAD+ precursors, such as nicotinamide mononucleotide (NMN) or 
nicotinamide riboside, attenuates age-related decline of muscle strength [1, 36], 
increases lifespan and healthspan [36]. In addition, oxidative metabolism and 
activation of SIRT1 and SIRT3 are enhanced in HFD-fed mice supplemented 
with NAD+ precursors [26]. In aged mice, NAD+ precursor supplementation also 
restored arterial SIRT1 activity, which was associated with improved vascular 
function and decreased aortic stiffness [37]. These findings demonstrate the 
feasibility of altering NAD+ bioavailability and subsequent SIRT activation.
More specifically, in HFD-fed mice, exogenous administration of the NAD+ 
precursor nicotinamide mononucleotide (NMN) was demonstrated to be a 
viable method of increasing endogenous NAD+ bioavailability and inducing 
SIRT1 activity, thereby attenuating the effects of the HFD and improving glucose 
tolerance and hepatic insulin sensitivity [16]. Long-term administration of NMN 
was also found to mitigate the age-associated decline in energy metabolism, 
insulin sensitivity and lipid metabolism [36]. Similarly, supplementation of 
HFD-challenged mice with nicotinamide riboside (another NAD+ precursor), 
also improved hepatic insulin sensitivity [26]. Additionally, an improved glucose 
tolerance and lipid profile were observed in mouse models of age-induced type 
2 diabetes upon NMN supplementation [16].
The NAD+ precursors nicotinic acid and nicotinamide have also been used 
to supplement HFD-challenged mice, increasing hepatic NAD+ levels and 
improving glucose tolerance. In one study, nicotinamide proved to be a more 
potent booster of NAD+ than nicotinic acid as it was also found to specifically 
alter the expression of SIRT1, SIRT2 and SIRT6 [38]. Lastly, Acipimox, a synthetic 
nicotinic acid analogue, has been shown to elevate NAD+ in C2C12 myotubes 
[39].
Together, these preclinical data suggest that dietary supplementation of NAD+ 
precursors can increase NAD+ levels and beneficially affect metabolic health.
2
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Inhibition of NADases increases NAD+ bioavailability and SIRT1 activity
Preclinical research has explored compounds that can inhibit the NADases 
CD38 [40] and poly(ADP-ribose) polymerase-1 (PARP-1), reducing the enzymatic 
competition for their shared substrate, for example by reducing their NAD+-
binding capacity, and thus enhancing SIRT1 activity (Fig. 2). Following this line 
of thought, a decrease in PARP-1 activity coincides with a rise in SIRT activity 
and NAD+ levels in worms [41] and mice [27], with PARP-1−/− mice displaying 
a leaner phenotype with higher energy expenditure compared with PARP-1+/+ 
mice. In line with this, in skeletal muscle, PARP-1 inhibitor-induced increases 
in SIRT1 activity were accompanied by improved mitochondrial function, 
enhanced energy expenditure and endurance performance [42]. In endothelial 
progenitor cells, PARP-1 inhibition also preserved cellular NAD+ content [43]. 
Similarly, Cd38 knockout mice have elevated NAD+ levels and are protected 
against HFD-induced metabolic inflexibility [44]. Moreover, the compounds 
apigenin, quercetin [45] and 78c [46] have all been demonstrated to enhance 
NAD+ levels and SIRT1 activity by inhibiting CD38.
How to boost NAD+ in humans?
Increasing NAD+ bioavailability through exercise and caloric restriction
Regular exercise and caloric restriction are well known to improve metabolic 
health in humans [47]. Alongside improving insulin sensitivity, metabolic 
flexibility and mitochondrial function, exercise also upregulates the expression 
of NAMPT in human skeletal muscle [48] (Fig. 2). Endurance-trained athletes 
have a twofold higher expression of NAMPT in skeletal muscle compared 
with baseline levels in sedentary obese, non-obese and type 2 diabetic 
individuals. After completing a 3 week training intervention, the non-obese 
group displayed increased NAMPT expression over baseline. NAMPT levels 
correlated positively with PGC-1α expression, mitochondrial content, maximal 
mitochondrial ATP synthesis in skeletal muscle and overall maximal aerobic 
capacity [48]. Concordantly, increased skeletal muscle SIRT3 content and PGC-1α 
expression were reported in men who were sedentary obese at baseline after 
a 12 week aerobic exercise intervention [49]. In a 6 week one-leg endurance 
exercise intervention, NAMPT protein levels only increased in the trained leg 
as compared with the untrained leg [34], further supporting the paradigm of 
activating the NAD+/SIRT axis through exercise and NAMPT induction.
Niels_Proefschrift.indd   28 08/12/2020   18:04:41
29
NAD+ Metabolism as a Target for Metabolic Health
Continuing, during a caloric restriction-induced weight-loss intervention, 
NAMPT and subsequent SIRT1 expression were found to be increased in adipose 
tissue of healthy obese participants [50] when compared with healthy lean 
participants. The participants were studied prior to, and after 5 months and 12 
months, of the intervention, with the intervention resulting in a loss of 17.1 % of 
body weight in the obese group. At baseline, gene expression of SIRT1, SIRT3, 
SIRT7 and NAMPT were significantly lower and PARP-1 activity significantly 
higher in the obese participants when compared with the lean group, indicating 
a state of low NAD+ bioavailability in obese individuals. With weight loss, SIRT1 
expression increased, whereas PARP-1 activity declined in the subcutaneous 
adipose tissue of the obese group [50]. Evidence that a state of obesity or 
overnutrition indeed lowers NAD+ levels also comes from studies of longer-term 
overfeeding using an HFD for 8 weeks in young, healthy men. This resulted in 
reduced NAD+ levels and SIRT activity in skeletal muscle when compared with 
baseline [51]. This was further supported by PGC-1α hyperacetylation in the same 
skeletal muscle biopsies. Concurring with these findings, a study in young adult 
monozygotic twins (n=26 obesity-discordant pairs and n=14 obesity-concordant 
pairs) reported that obesity was associated with lower NAD+/SIRT axis activation 
in subcutaneous adipose tissue [14]. Together, these findings suggest that a state 
of energy abundance is prone to reduce the activity of the NAD+/SIRT axis and 
that inducing a state of energy demand may aid to restore NAD+ levels.
Supplementation of NAD+ precursors
From a human dietary perspective, Trp, nicotinic acid, nicotinamide, and 
nicotinamide riboside are the predominant NAD+ precursors currently used in 
intervention trials, with nicotinamide riboside being the latest addition to the 
array of dietary NAD+ precursors (Fig. 1). The efficacy and safety of treatment 
with each of these NAD+ precursors are discussed in more detail below.
Nicotinamide Phase 0 and phase 1 trials have demonstrated tolerance and safety 
of nicotinamide in daily pharmacological doses up to 3.5 g [52-56] and single 
doses of up to 6 g [57-59]. However, at doses above this, nicotinamide can become 
hepatotoxic [60].
Nicotinic acid and Acipimox Nicotinic acid is the most effective pharmacological 
drug available for elevating HDL-cholesterol and lowering total cholesterol, LDL-
2
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cholesterol and triacylglycerol levels, thereby reducing the overall cardiovascular 
risk profile of the user [61]. However, nicotinic acid can elevate plasma glucose 
levels by inducing insulin resistance following a rebound increase in circulating 
NEFAs [62]. This poses a challenge when using nicotinic acid as (add-on to 
statin) therapy for dyslipidaemia in individuals with impaired glucose tolerance, 
impaired fasted glucose or type 2 diabetes, with the reduction in overall 
cardiovascular disease risk on one hand and compromised glycaemic control 
on the other. The worsening of hyperglycaemia with nicotinic acid use would 
possibly require additional therapeutic fine tuning to be implemented on an 
individual level to maintain glycaemic control. Alternatively, a reduction in 
the dose of nicotinic acid could improve glycaemic control, however, this may 
require acceptance of reciprocal compromise of the lipid profile or additional 
therapy to be initiated.
A large clinical trial evaluated the efficacy of nicotinic acid as a treatment for 
hypercholesterolaemia, with a daily dose of 1–3 g, for a duration of 96 weeks [63]. 
Overall, nicotinic acid was well tolerated. However, flushing was reported as a 
major adverse event. In contrast to nicotinamide, nicotinic acid is a vasoactive 
compound [64] and activates the G protein-coupled receptor, GPR109A, thereby 
inducing flushing [65]. In an attempt to reduce the occurrence of flushing and 
improve adherence, synthetic and extended- and sustained-release formulations 
of nicotinic acid were developed. Acipimox is a synthetic nicotinic acid analogue 
and, thereby, an NAD+ precursor that can be utilised by the Preiss–Handler 
pathway (Fig. 1). Although Acipimox displays the vasoactive properties that 
lead to flushing, we previously showed that treating individuals with type 2 
diabetes with Acipimox for 2 weeks resulted in an improvement in skeletal 
muscle mitochondrial function [39]. In two other trials, Acipimox therapy 
improved insulin sensitivity [66, 67]. However, Acipimox is mainly used for 
lowering circulating NEFA levels and these human experiments do not allow us 
to conclude whether the beneficial effects observed were due to NAD+ boosting 
actions alone, although, in the first trial [39], the improved mitochondrial 
function with Acipimox therapy was accompanied with elevated (as opposed 
to lower) NEFA levels due to a known rebound effect. Unfortunately, the newer 
formulations of nicotinic acid have been associated with a higher occurrence 
of gastro-intestinal complaints, hepatotoxicity and hyperglycaemia, and a 
decreased HDL-cholesterol-raising efficacy compared with regular nicotinic acid 
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[61]. Together, the side effects limit the use of nicotinic acid for further clinical 
exploration and implementation.
NADH NADH supplementation has also been used to boost NAD+ levels in 
humans. In a small study, 80 adults with chronic fatigue syndrome received 
daily doses of 20 mg of NADH combined with 200 mg of coenzyme Q10 and were 
compared with placebo-treated individuals [68, 69]. The intervention improved 
reported fatigue [68] and increased maximal heart rate after 8 weeks of treatment 
[69] but did not alter body weight or blood pressure. Additionally, in peripheral 
blood mononuclear cells (PBMCs), the intervention significantly reduced NAD+ 
levels and increased NADH levels, thus, significantly lowering the NAD+/NADH 
ratio over baseline. Furthermore, ATP content and citrate synthase activity were 
significantly increased in PBMCs [68]. Unfortunately, it cannot be distinguished 
whether the observed results were solely attributed to NADH supplementation 
considering the co-administration of coenzyme Q10 in this study.
Nicotinamide riboside In contrast to nicotinic acid, nicotinamide riboside is 
not vasoactive and does not cause flushing [70], thereby overcoming one of 
the adverse effects of nicotinic acid supplementation. In a recently published 
placebo-controlled, double-blind, randomised, phase 1 crossover trial, a daily 
dose of 1000 mg of nicotinamide riboside for 6 weeks was demonstrated to be 
well tolerated and adverse events were no more frequent than in the placebo 
arm [71]. These findings are confirmatory of the preceding phase 1 trials [72-74]. 
Additionally, nicotinic acid adenine dinucleotide (NAAD) has been confirmed as 
a reliable and sensitive biomarker for assessing changes in NAD+ levels following 
nicotinamide riboside supplementation [72].
Daily nicotinamide riboside supplementation of up to 2000 mg can effectively 
enhance blood NAD+ levels, achieving higher steady-state concentrations over 
baseline [73]. Concordantly, a more recent study demonstrated that nicotinamide 
riboside supplementation increased NAAD and NAD+ levels by ~60% in PBMCs. 
In this study, the effect of 6 weeks of nicotinamide riboside supplementation vs 
placebo was tested in healthy middle-aged and older adults. It was also found 
that 6 weeks of nicotinamide riboside supplementation tended to improve 
systolic blood pressure and pulse-wave velocity, both of which are markers 
of cardiovascular health [71]. However, no effect of nicotinamide riboside 
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supplementation was found on physical performance outcomes, such as the 4 
metre or 6 minute walk test, handgrip strength or maximum torque. Moreover, 
metabolic variables, such as VO2max during a treadmill exhaustion test, 
respiratory exchange ratio, and insulin sensitivity assessed by an IVGTT, did 
not differ between the groups. From these findings, it was concluded that long-
term nicotinamide riboside supplementation is a viable strategy for enhancing 
NAD+ in humans and potentially has cardiovascular benefits that require further 
exploration in larger trials.
Most recently, an RCT of daily treatment with 2000 mg of nicotinamide 
riboside for 12 weeks was reported, evaluating safety, insulin sensitivity and 
other metabolic variables in 40 healthy, obese, middle-aged men [75]. Overall, 
nicotinamide riboside was well tolerated and only four adverse events were 
reported: pruritus, excessive sweating, bloating and transient changes in stools. 
Nicotinamide riboside supplementation increased NAD+ metabolism, as was seen 
by an increase in urinary metabolites. Using the hyperinsulinaemic–euglycaemic 
clamp technique, insulin sensitivity was found to be unchanged before and 
after supplementation and when compared with the placebo condition. In 
addition, resting energy expenditure and respiratory exchange ratio were not 
affected by nicotinamide riboside supplementation. Also, intrahepatic lipid 
content and body composition remained unchanged in the treatment group vs 
baseline and compared with the placebo group. Finally, a significant but modest 
increase in serum triacylglycerol levels was detected after nicotinamide riboside 
supplementation when compared with baseline values. The authors concluded 
that this study was underpowered and future studies should be larger and focus 
on other variables of metabolic health, such as intrahepatic lipid content, which 
showed significant changes in rodents [76, 77] treated with nicotinamide riboside 
and approached significance in this study.
Tryptophan Another dietary NAD+ precursor, Trp, is an essential amino 
acid and is metabolised into NAD+ through de novo biosynthesis in the liver 
and kidneys [20]. This route is critical for maintaining the NAD+ pool, even 
though the conversion ratio of Trp to NAD+ is low in humans, averaging 60:1 
[78]. Nonetheless, Trp is deemed capable of meeting the metabolic demands of 
NAD+ metabolism in nicotinic acid- and nicotinamide-deficient diets, and is 
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well tolerated at high doses, between 30 and 50 mg/kg bodyweight, apart from 
drowsiness/sleepiness [79].
Recently, higher circulating Trp levels were identified as a predictive marker for 
the development of type 2 diabetes in a large prospective Chinese cohort [80]. 
However, to date, no dietary supplementation studies are available that directly 
assess whether boosting NAD+ through Trp might be metabolically beneficial 
in humans.
Inhibition of NAD+ consumers
The drawback of pharmacological strategies involving CD38 and PARP-1 
inhibition is the original intended therapeutic use in malignancies [81, 82]. As 
such, no clinical trials with PARP-1 or CD38 inhibitors that focus on improving 
metabolic variables have been conducted in humans. This, however, does not 
imply that this strategy must be abandoned altogether, as a viable work-around 
to exploit the theoretical metabolic benefit of inhibition of NAD+ consumers may 
present itself in due time, allowing us to assess their efficacy in clinical trials.
Future perspective
The current evidence base from preclinical research on NAD+ is setting the 
stage for trials in humans by identifying the points at which intervening in the 
NAD+ metabolism process seems to be clinically and physiologically relevant 
(see Summary text box). Even though many results have not been replicated 
in humans at this point in time, phase 0 and phase 1 trials have proven the 
feasibility and safety of NAD+ boosting in humans. As most evidence that 
increased in NAD+ levels may be beneficial to human metabolism comes from 
indirect observations, such as exercise and weight loss interventions, the 
assessment of efficacy in well-powered phase 2 and phase 3 trials is urgently 
awaited in order to draw clear conclusions. Additionally, studies in metabolically 
disturbed individuals must be considered as these are more in line with the 
preclinical models used. To date, generally healthy populations have been 
included in studies in this area, in which the range of improvement may be too 
small to detect significant changes. The combination of strategies to increase 
NAD+, such as exercise, caloric restriction, or CD38 and PARP-1 inhibitors, with 
NAD+ precursor supplementation may also be considered, to evaluate added 
2
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efficacy of such approaches, as seen in mice [15] (see Recommendations text 
box).
Currently, a number of clinical trials (Table 1) are underway in which NAD+ 
precursor supplementation is being used to improve (often disturbed) metabolic 
health variables. The coming years will prove whether the promising results 
observed in preclinical studies can indeed find human translation.
Recommendations for future NAD+-boosting strategies
• Combining NAD+-boosting strategies may be more effective at increasing 
NAD+ bioavailability than focusing on a single strategy alone 
• Future clinical trials should focus on individuals with metabolic 
disturbances, such as those with type 2 diabetes or the elderly
Summary of NAD+-boosting strategies in humans
• Exercise and caloric restriction enhance NAMPT expression and, thereby, 
NAD+ levels 
• NAD+ precursors can elevate NAD+ levels and are generally well tolerated, 
especially nicotinamide riboside 
• Human clinical trials investigating the impact of CD38 and PARP-1 
inhibitors or Trp on NAD+ availability are lacking 
• Conclusive evidence that increasing NAD+ levels attenuates metabolic 
disturbances in humans is also still eagerly awaited
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Objective. Skeletal muscle mitochondrial function and energy metabolism 
displays day-night rhythmicity in healthy, young individuals. 24-h rhythmicity 
of metabolism has been implicated in the etiology of age-related metabolic 
disorders. Whether day-night rhythmicity in skeletal muscle mitochondrial 
function and energy metabolism is altered in older, metabolically comprised 
humans is so far unknown.
Methods. Twelve male overweight volunteers with impaired glucose tolerance 
and insulin sensitivity stayed in a metabolic research unit for 2 days under free 
living conditions with regular meals. Indirect calorimetry was performed at 
five time points (8AM, 1PM, 6PM, 11PM, 4AM), followed by a muscle biopsy. 
Mitochondrial oxidative capacity was measured in permeabilized muscle fibers 
using high-resolution respirometry.
Results. Mitochondrial oxidative capacity did not display rhythmicity. The 
expression of circadian core clock genes BMAL1 and REV-ERBA showed a 
clear day-night rhythm (p < 0.001), peaking at the end of the waking period. 
Remarkably, the repressor clock gene PER2 did not show rhythmicity, whereas 
PER1 and PER3 were strongly rhythmic (p < 0.001). On the whole-body level 
resting energy expenditure was highest in the late evening (p < 0.001). Respiratory 
exchange ratio did not decrease in the night, indicating metabolic inflexibility.
Conclusions. Mitochondrial oxidative capacity does not show a day-night 
rhythm in older, overweight participants with impaired glucose tolerance and 
insulin sensitivity. In addition, gene expression of PER2 in skeletal muscle 
indicates that rhythmicity of the negative feedback loop of the molecular clock 
is disturbed.
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Introduction
Metabolic processes in the human body are highly dynamic and adapt rapidly 
to increased demand during physical activity and to energy intake in the 
postprandial period. The body’s circadian timing system is intertwined with 
metabolism at various levels, thereby anticipating metabolic challenges such as 
increased energy demand during the daytime. It is therefore not surprising that 
acute and chronic disturbance of the biological clock are related to disturbances 
in metabolic health. For example, chronic shift work is associated with increased 
risk for type 2 diabetes [1] and simulated shift work in human volunteers leads to 
glucose intolerance [2]. Furthermore, we have recently shown that a rapid day-night 
shift in healthy humans leads to a reduction in insulin sensitivity, which could 
specifically be attributed to a reduction in skeletal muscle insulin sensitivity [3].
In humans, circadian rhythmicity (i.e. 24-h rhythm that persists under constant 
conditions) or a 24-h day-night rhythm (i.e. recurring 24-h rhythm under free 
living conditions) has been observed for a variety of metabolic processes. One of 
the earliest reports observed higher glucose tolerance in the morning than in the 
afternoon [4]. Subsequent investigations showed rhythmicity in metabolic gene 
expression [5; 6], protein abundance [7] and parts of the lipidome and metabolome 
[8]. We recently reported a pronounced day-night rhythm in human skeletal 
muscle mitochondrial oxidative capacity in young, lean, healthy volunteers [9]. 
Mitochondrial oxidative capacity was highest in the late evening, which was 
consistent with the pattern in whole body energy expenditure. We also observed 
a day-night rhythm in the expression of the biological clock genes BMAL1, PER2 
and CRY1, suggestive of metabolic and circadian cohesion in skeletal muscle.
Obesity, aging and insulin resistance have been reported to result both in 
decreased mitochondrial oxidative capacity [10], as well as in reduced metabolic 
flexibility [11]. Therefore, it can be suggested that a reduced mitochondrial 
function mediates this metabolic inflexibility in skeletal muscle.
In light of these findings, one can hypothesize that the day-night rhythm in 
skeletal muscle mitochondrial oxidative capacity we observed previously in 
young, healthy individuals is a prerequisite for metabolic health. However, so 
far human data about the day-night rhythmicity of skeletal muscle mitochondrial 
5
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capacity and energy metabolism in older, metabolically comprised individuals is 
lacking. Here we provide a detailed characterization of 24-h energy and substrate 
metabolism, including rhythmicity in skeletal muscle oxidative capacity using 
tissue from sequentially sampled skeletal muscle biopsies, in older individuals 
with a comprised metabolic health.
Materials and methods
Participants
Male, overweight volunteers between the ages of 40 – 75 years were recruited 
through advertisements in the vicinity of Maastricht. Participants were non-
smokers and generally healthy, as determined by a medical questionnaire and 
examination by a physician. Only participants with a habitual bed time of 11 PM 
± 2 hours and 7 – 9 hours sleep per day were included. Participants were excluded 
from the study if they performed shift work or traveled across more than one 
time zone in the three months before the study. By means of the Morningness-
Eveningness Questionnaire Self-Assessment Version 1.3 (MEQ-SA; Score 
between: 35 - 70) we excluded extreme morning or evening types. To establish 
volunteers with a reduced metabolic health, we selected participants with 
impaired glucose tolerance and insulin sensitivity. To that end, participants had 
to fulfill at least one of 4 criteria in order to be included into the study: 1) Impaired 
fasting glucose (IFG) 6.1mmol/L - 6.9 mmol/L; 2) impaired glucose tolerance (IGT) 
7.8 mmol/L - 11.1 mmol/L 2 hours after 75 gram glucose consumption; 3) HbA1c 
of 5.7 – 6.4%; or 4) low insulin sensitivity defined as glucose clearance rate ≤ 
360ml/kg/min according to the OGIS model [12]. Criteria 1 and 2 are derived from 
the World Health Organization recommendations [13], criteria 3 is according to 
the definition of prediabetes from the American Diabetes Association [14]. The 
study was conducted in accordance with the principles of the declaration of 
Helsinki and approved by the Ethics Committee of the Maastricht University 
Medical Center. All participants provided written informed consent. The study 
was registered at https://clinicaltrials.gov with identifier NCT03733743.
Study conditions
During a 7-day run-in period prior to admission to the research facility, 
participants were instructed to adhere to a fixed lifestyle that resembled the 
experimental conditions during the overnight stay. During this run-in period 
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participants had to refrain from alcohol and caffeinated drinks, sleep only 
between 11 PM and 7 AM, and only eat three meals per day at 8 AM, 1 PM and 
6 PM. Standardized meals with fixed caloric content adjusted to the participants’ 
needs (described below) were provided for the last two days before the visit to 
the lab. Furthermore, participants were instructed to refrain from exercise for 
the last three days of the run-in period. Adherence to the activity protocol and 
sleeping times at home was checked using actigraphy (Actiwatch) and a sleep 
diary. Meal times were registered in a food diary for one week, and meal contents 
were noted for the last three days before the visit to the lab.
Overnight visit
All study procedures were performed as described previously in the study by 
van Moorsel et al. [9]. Participants were admitted to the research unit at 12 PM on 
test day 1 and stayed for 44 h in total, under standardized conditions mimicking 
a real-life situation. The first test day was used to standardize and monitor 
meals, physical activity and bedtime. Meals were provided at 1PM and 6PM in 
our research facilities. One hour after every meal, participants went for a 15-
minute low-intensity walk accompanied by a researcher in order to standardize 
physical activity. Directly hereafter, participants were instructed to stand for 15 
minutes before they were allowed to sit again. Between meals, physical activity 
and tests, the participants stayed in a respiration chamber; a small room with 
a bed, toilet, sink, desk, chair, TV and computer. At 11 PM, the lights of the 
respiration chamber were turned off and the participants were instructed to try 
to sleep. During the first night, sleeping metabolic rate was measured by whole-
room indirect calorimetry (Omnical, Maastricht Instruments, Maastricht, The 
Netherlands) [15].
On the second test day, participants were woken up at 6:30 AM and participants 
swallowed a telemetric pill for measurement of core-body temperature (Equivital, 
Philips-Respironics, Murrysville PA, USA). Next, an intravenous cannula was 
placed in the forearm for subsequent blood-draws. The first blood-draw was at 8 
AM, followed by an indirect calorimetry measurement using a ventilated hood 
while awake and at rest in supine posture to calculate resting energy expenditure 
and substrate oxidation. Directly hereafter, the first skeletal muscle biopsy was 
taken (described below). These measurements (blood draw, indirect calorimetry 
and skeletal muscle biopsy) were repeated five times within 24-h: at 8 AM, 1 PM, 
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6 PM, 11 PM and at 4 AM of the next day. Additional blood samples were taken at 
2-hour intervals (10 AM, 12 PM, 2 PM, 4 PM, 8 PM, 10 PM, 0 AM, 2 AM, 6 AM and 
8 AM). The meals on the second test day were provided immediately after the 
muscle biopsies and were thus delayed by approximately 1 hour compared to the 
run-in period and the first test day. After the 11 PM biopsy, participants returned 
to the respiration chamber to sleep with lights off. At 4 AM, the participants 
were woken up, and the last measurements were performed, after which the 
subject was allowed to sleep until 7 AM. After the 8 AM blood draw the study 
protocol ended. All indirect calorimetry measurements and muscle biopsies were 
performed in normal room light conditions.
Study meals
Two days before admission to the metabolic research unit, and during the study, 
the participants were provided with standardized meals that were based on 
Dutch dietary guidelines and matched for energy expenditure. Caloric intake 
for consumption at home was calculated by multiplying the estimated resting 
metabolic rate, obtained with the Harris-Benedict formula [16] with an activity 
factor of 1.5. Participants were provided with optional extra snacks to eat with 
their meals if they were still hungry, up to an activity factor of 1.7. For the first 
test day in the laboratory, energy requirement was calculated by multiplying 
the estimated resting metabolic rate with an activity factor of 1.35, because of 
limited physical activity in the research facility. For the second test day, energy 
requirement was calculated by multiplying the sleeping metabolic rate of the first 
study night (measured by whole-room indirect-calorimetry) by 1.5.
During the study days, participants received 3 meals daily. Breakfast accounted 
for ~ 21 energy% (E%), lunch for ~ 30 E% and dinner for ~ 49 E%. Daily 
macronutrient composition was ~ 52 E% as carbohydrates, ~ 31 E% as fat (~ 9 E% 
saturated) and ~ 14 E% as protein. Breakfast and lunch were bread based and thus 
the percentage of energy from carbohydrates was higher compared to the dinner. 
No snacks or drinks other than water were provided in-between meals.
Skeletal muscle biopsies
Five skeletal muscle biopsies were obtained from the m. vastus lateralis 
according to the Bergström method [17] under local anesthesia (1% lidocaine, 
without epinephrine). Each biopsy was taken from a separate incision at least 2 
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cm from the previous incision, moving from distal to proximal. The first biopsy 
was randomly taken from the left or right leg, and each subsequent biopsy was 
taken from the other leg. After the biopsies of 11 PM and 4 AM, participants 
lay in bed and tried to sleep. All biopsies were taken at least 4 hours after the 
last meal to prevent any acute influence of meal ingestion. Part of the biopsy 
was immediately placed in ice-cold preservation medium (BIOPS, OROBOROS 
Instruments, Innsbruck, Austria) and used for the preparation of permeabilized 
muscle fibers and subsequent measurement of mitochondrial oxidative capacity. 
The remaining part of the muscle biopsy was immediately frozen in melting 
isopentane and stored in -80 °C until further analysis.
High resolution respirometry
Permeabilized muscle fibers were prepared freshly from biopsies, as described 
previously [18]. In permeabilized muscle fibers, oxygen consumption was 
measured by high-resolution respirometry using an Oxygraph (OROBOROS 
Instruments). During the experiment, a multisubstrate-uncoupler protocol 
with malate, octanoylcarnitine, ADP, glutamate, succinate and carbonylcyanide 
p-trifluoromethoxyphenylhydrazone (FCCP) was performed, as described 
previously [19]. The integrity of the outer mitochondrial membrane was assessed 
by the addition of cytochrome C upon maximal coupled respiration. All oxygen 
consumption measurements were performed in quadruplicate.
Indirect calorimetry
Oxygen consumption and carbon dioxide production were measured with an 
automated respiratory gas analyzer using a ventilated hood system (Omnical; 
IDEE, Maastricht, the Netherlands) and were used to calculate whole-body 
energy expenditure, respiratory exchange ratio (RER), glucose- and fat oxidation. 
Calculations of energy expenditure and substrate oxidation were made with the 
assumption of a negligible protein oxidation [20].
Core body temperature
After waking up on the second test day, participants ingested a thermometer 
capsule (Equivital, Philips-Respironics, Murrysville PA, USA) to measure core-
body temperature (CBT) for 24-h. Due to premature excretion of the capsule or 
technical failure, complete CBT measurements were obtained in 11 participants 
only.
5




Western blot analyses were performed in Bioplex-lysates of human muscle tissue. 
Protein concentration was determined with the Bio-Rad RC/DC protein assay 
kit (Bio-Rad Laboratories, Veenendaal, The Netherlands). Equal amounts of 
protein were loaded on 12% TGX stain-free gels (Bio-Rad Laboratories) or 4-12% 
Bolt gradient gels (Novex, Thermo Fisher Scientific, Bleiswijk, The Netherlands). 
Proteins were transferred to nitrocellulose with the Trans-Blot Turbo transfer 
system (Bio-Rad Laboratories). Protein load was controlled in the stain-free gels 
[21] and blots and with the REVERT stain (REVERT total protein stain, LI-COR, 
Lincon, USA) in the 4 – 12% gradient gels. Primary antibodies: a cocktail of 
mouse monoclonal antibodies directed against human OXPHOS (dilution 1:5,000; 
ab110411, Abcam, Cambridge, UK), two mitochondrial markers directed against 
TOMM20 (dilution 1:10,000; ab186734; Abcam), porin/VDAC (dilution 1:5,000; sc-
8828, Santa Cruz Biotechnology, Dallas, Texas), FIS-1 (dilution 1:1000, sc-98900, 
Santa Cruz Biotechnology, Dallas, Texas), PINK-1 (dilution 1:2000, sc-33796, Santa 
Cruz Biotechnology, Dallas, Texas) and OPA-1 (dilution 1:2500, 612,606, Becton 
Dickinson). The specific proteins were detected using secondary antibodies 
conjugated with IRDye680 or IRDye800, and were quantified with the CLx 
Odyssey Near Infrared Imager (Li-COR, Westburg, Leusden, The Netherlands).
Gene transcript quantification
RNA was isolated from 10 mg of muscle material by TRIzol lysis (Qiagen, Hilden, 
Germany). RNA was further purified by the RNeasy kit from Qiagen (Hilden, 
Germany). RNA yield was measured using a NanoDrop spectrophotometer 
(Thermo Fisher Scientific, Waltham, USA). The high-capacity RNA-to-cDNA 
kit from Applied Biosystems (Foster City, USA) was used for transcribing 200 
ng RNA to cDNA. Transcript abundance was determined using a CFX384 Real-
Time System (Biorad-Laboratories, Veenendaal, NL). To minimize the variability 
in reference gene normalization, the geometric mean of three reference genes 
(RPL26, GUSB and CYPB), which were individually stably expressed in time, was 
used. This geometric mean was used as the internal reference for comparative 
gene expression analysis in the remainder of the study [22].
Statistics
Data are presented as mean ± SEM (standard error of the mean) unless indicated 
otherwise. Statistical analyses were performed with the use of IBM Statistical 
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Package for Social Sciences for MAC, version 23 (SPSS, Inc.). The effect of time 
on outcome variables was analyzed by repeated measures ANOVA. In case 
of significance, Bonferroni adjusted post-hoc analyses were applied to look at 
differences between specific time-points. Statistical significance was defined as a 
p-value < 0.05. In addition, if repeated measures ANOVA resulted in a significant 
effect of time for targets of mRNA and protein expression and oxidative capacity 
states, we tested for rhythmicity using the JTK_Cycle package [23] in R 3.2.1. 
For this analysis, values were normalized to subject mean prior to analysis.
Results
Subject characteristics and circadian entrainment period
Twelve male volunteers with a mean age of 65 ± 9 years who were overweight 
(BMI: 30.3 ± 2.7 kg/m2) participated in the study. Subject characteristics are 
summarized in Table 1. A general overview of the study procedures is depicted 
in Figure S1. Core body temperature (CBT), which is under control of the central 
biological clock [24], was measured for 24 hours beginning on day 2, and showed 
a typical day-night rhythm. The nadir occurred on average around 1 AM, 
indicating similar circadian entrainment of the participants (Figure S2).
Table 1 – Descriptive characteristics during screening
Parameter
Age (years) 65 ± 9
Height (m) 1.78 ± 0.05
Body weight (kg) 96 ± 12
BMI (kg/m2) 30.3 ± 2.7
Body fat (%) 33 ± 4
Fasting plasma glucose (mmol/L) 5.7 ± 0.4
Fasting plasma insulin (µIU/mL) 13.8 ± 8.5
2-h plasma glucose (mmol/L) 7.3 ± 1.5
HbA1c (%) 5.3 ± 0.5
Glucose clearance (ml/kg/min) 327 ± 38
MEQ-SA score 57 ± 9
Subject’s characteristics at baseline. Values are depicted as mean ± SD (n = 12). MEQ-SA 
Morningness-Eveningsness Questionnaire Self-Assessment Version.
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Mitochondrial oxidative capacity lacks a day-night rhythm
To determine potential rhythmicity in mitochondrial oxidative capacity, we 
performed high-resolution respirometry in freshly isolated permeabilized 
muscle fibers sampled at 5 timepoints over a normal day-night cycle. ADP-
stimulated (state 3) mitochondrial respiration was assessed upon consecutive 
addition of octanoylcarnitine (O), glutamate (G) and succinate (S), with malate 
(M) being present as a supportive substrate (Figure 1A - C). Finally, we assessed 
maximal uncoupled respiration (state U) by titration of the chemical uncoupler 
FCCP (Figure 1D). Although we found a time effect in all mitochondrial 
respiration rates measured (State 3MO p = 0.005, State 3MOG p = 0.027, State 
3MOGS p = 0.032, State U p = 0.043), no difference between the peak and nadir 
could be detected in any of the states (Bonferroni adjusted multiple testing p 
> 0.05). Furthermore, we performed rhythmicity analysis (JTK_Cycle) to see if 
mitochondrial respiration exhibited ~ 24-h rhythmicity. Apart from a small but 
significant day-night rhythm for state 3MO respiration, with the peak at 8 AM 
and trough at 11 PM (35.7 ± 3.4 vs. 29.4 ± 2.6 pmol/mg/s, 8 AM vs. 11 PM, JTK_Cycle 
p = 0.016), mitochondrial respiration did not display day-night rhythmicity. Thus, 
state 3MOG and state 3MOGS respiration as well as maximal oxidative capacity 
(state U) did not display significant 24-h day-night rhythmicity (JTK_Cycle p 
> 0.05). Figure 1 further illustrates this lack of rhythmicity, as mitochondrial 
respiration rates merely show a flat line over time, especially when compared 
to our previous findings in young, healthy volunteers [9].
To investigate if mitochondrial content is variable over the day, we measured 
protein levels of subunits of the oxidative phosphorylation complexes. The 
oxidative phosphorylation complexes I – V did not show a time effect and 
remained at similar levels throughout the day (Figure 2A - F). To further confirm 
this, we measured protein content of two mitochondrial membrane proteins 
TOMM-20 and VDAC, which also showed no rhythmicity, suggesting that 
mitochondrial content does not change over 24 hours (Figure 2G – H).
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Figure 1 – Mitochondrial oxidative capacity in skeletal muscle does not have a day-
night rhythm. ADP-stimulated respiration of permeabilized muscle fibers fueled with 
(A) the lipid substrate octanoylcarinitine (state 3 MO); (B) addition of complex I substrates 
(state 3 MOG); (C) addition of substrates for parallel electron input into complex I and 
II (state 3 MOGS). Maximal uncoupled respiration after FCCP (State U) titration (D). For 
reference, we depicted the respiration states from our previous study in young, healthy, 
lean subjects [9] using dotted lines. M, malate; O, octanoylcarnitine; G, glutamate; S, 
succinate. The dark grey area represents the sleeping period (12AM - 7AM). Data depicts 
oxygen consumption per mg wet weight per second and is shown as mean ± SEM. * p < 
0.05 for effect of time in all states.
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Figure 2 – Mitochondrial respiratory chain proteins are not rhythmic. Proteins levels 
of oxidative phosphorylation complexes I – V (A - E). Representative western blot of 
one subject depicting the oxidative phosphorylation complexes of all time points (F). 
Protein levels of the two mitochondrial membrane proteins TOMM-20 and VDAC (G 
- H). Jointly, these data indicate that mitochondrial content does not possess 24-hour 
rhythmicity. Representative western blot images are displayed below the quantification 
graphs. Proteins of interest were normalized to total protein content using stain-free 
technology. The dark grey area represents the sleeping period (12AM - 7AM). Data is 
presented as mean ± SEM.
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We previously found that markers of mitochondrial fusion and fission in 
lean, healthy volunteers exhibited diurnal variations, which paralleled the 
pattern of mitochondrial oxidative capacity [9]. We therefore investigated 
markers of mitochondrial fusion (OPA-1), fission (FIS-1) and mitophagy (PINK-
1). Interestingly, in contrast to our previous findings, here only OPA-1 levels 
showed a time effect (p = 0.003, Figure 3A), while FIS-1 and PINK-1 were non-
rhythmic over the day. Together this could mean that the dynamic capacity of 
mitochondria to constantly undergo cycles of fusion and fission is impaired in 
these participants.
Figure 3 – Regulators of mitochondrial dynamics. Proteins levels of markers for 
mitochondrial fusion: OPA-1 (A), mitochondrial fission: FIS-1 (B) and mitophogy: PINK-1 
(C). Representative western blots are depicted below the graphs. Marker proteins indicate 
no mitochondrial network remodeling over the 24-h period. Proteins of interest were 
normalized to total protein content using stain-free technology. The dark grey area 
represents the sleeping period (12AM - 7AM). Data is presented as mean ± SEM. * p < 
0.05 for effect of time in all states.
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Whole body substrate oxidation shows metabolic inflexibility
To investigate if whole-body energy expenditure and substrate oxidation display 
day-night variation, we performed indirect calorimetry in the resting state at the 
5 timepoints of the mitochondrial function assessment, i.e. prior to taking each 
muscle biopsy. In addition, we plotted the whole-room calorimetry measurement 
from the first night in order to verify that measurements obtained at 4 AM after 
waking up were similar to an undisturbed condition while asleep (Figure 4A 
- D). Resting metabolic rate (RMR) showed clear differences over the day, with 
lowest values occurring at 8 AM and 4 AM and peak energy expenditure at 11 
PM at the end of the waking period (p < 0.001 for the time effect; p = 0.001 for 
Bonferroni adjusted post-hoc analysis 8 AM vs. 11 PM; Figure 4A). Respiratory 
exchange ratio (RER) increased over the day and plateaued in the late evening 
and night, showing increased reliance on carbohydrate oxidation over the day 
(Figure 4B). Statistical analysis revealed a significant time effect for RER (p < 0.001 
for the time effect). The mean difference between peak and trough was 0.05 ± 
0.01 (0.80 ± 0.01 vs. 0.85 ± 0.01, 8 AM vs. 4 AM (p = 0.001 for Bonferroni adjusted 
post-hoc analysis), illustrating the relatively modest day-night variation in these 
older, insulin resistant participants. For reference, the day-night variation in RER 
in lean, healthy volunteers in our previous study was 0.08 ± 0.02 [9]. Interestingly, 
RER remained high under fasting conditions at 4 AM even though the last meal 
was provided at 7 PM in the evening. As exemplified by the RER, carbohydrate 
oxidation increased during the day with highest values at 11 PM (p < 0.001 for 
the overall time effect; p < 0.001 for Bonferroni adjusted post-hoc analysis; Figure 
4C). Fat oxidation decreased accordingly, with highest fat oxidation at 8 AM 
(p < 0.001 for the overall time effect; p = 0.003 for Bonferroni adjusted post-hoc 
analysis; Figure 4D).
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Figure 4 – Respiratory exchange ratio shows increase in carbohydrate oxidation over 
the day. Whole-body resting energy expenditure (A), respiratory exchange ratio (B), 
carbohydrate oxidation (C), fat oxidation (D). For reference, we depicted the measurements 
from our earlier study in young, healthy, lean subjects [9] using dotted lines. The dark 
grey areas represent the sleeping periods (12AM - 7AM) before and at the end of the test 
day. Data is presented as mean ± SEM. * p < 0.05 for effect of time.
24-h plasma metabolites
We obtained 15 blood samples over the 24-h day-night cycle on test day 2 to 
determine circulating levels of metabolites. Glucose and insulin levels peaked 
in the postprandial periods and decreased rapidly after all meals (Figure 5A 
and 5B). Interestingly though, plasma glucose remained elevated 4 hours after 
the dinner (11 PM), while 4 hours after the breakfast (1 PM) glucose levels had 
decreased to the fasting level. Similar to the plasma glucose pattern, insulin 
levels remained high 4 hours after dinner, whereas insulin levels had decreased 
to the fasting level 4 hours after breakfast. Together, these results suggest that 
insulin sensitivity is lower in evening than in the morning. Free fatty acid (FFA) 
levels were high under fasting conditions in the morning and decreased after 
breakfast (9 AM) and lunch (2 PM) (Figure 5C). During the night FFA increased 
again with a peak at 2 AM in agreement with the notion that during periods 
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of fasting FFA are released from adipose tissue to provide energy. Triglyceride 
(TG) levels increased over the course of the day and after each meal, and kept 
increasing until 12 AM (midnight) – 5 hours after the last meal (Figure 5D). 
Throughout the sleeping period (12 AM until 7 AM), TG levels decreased until 
they reached fasting levels in the next morning.
Figure 5 – Daily variations in glucose, insulin, FFA and triglyceride are predominantly 
influenced by feeding. Plasma levels of glucose (A), insulin (B), free fatty acids (C), 
triglycerides (D). For reference, we depicted the measurements from our earlier study 
in young, healthy, lean subjects [9] using dotted lines. The dark grey area represents the 
sleeping period (12AM - 7AM). Data is presented as mean ± SEM. * p < 0.05 for effect of 
time.
Muscle clock gene analysis indicates phase shift of PER2 and CRY1
We and others previously reported that clock gene expression exhibit 24-h 
day-night rhythmicity in human skeletal muscle of lean volunteers, both when 
measured in human muscle biopsies and in primary human myotubes [6; 9; 25]. 
Here we investigated whether the core clock genes display a day-night rhythm 
in older, metabolically compromised volunteers. To this end, we measured 
the positive (BMAL1, CLOCK and REV-ERBa) and the negative (PER2 and 
CRY1) regulators of the muscle clock in all 5 biopsies over the day (Figure 6). 
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Consistent with our previous findings [9], BMAL1 and REV-ERBa exhibited 
robust oscillations with a peak at the end of the waking period and a trough 
at noon (BMAL1 p < 0.001 for the overall time effect; JTK_Cycle p < 0.001; REV-
ERBa p < 0.001 for the overall time effect; JTK_Cycle p < 0.001; Figure 6A and 6E 
respectively). In contrast, the negative regulator CRY1 peaked in the morning 
(p = 0.084 for the overall time effect, JTK_Cycle p = 0.005; Figure 6D). Even more 
remarkable, the expression of the negative regulator PER2 showed that there 
was no day-night rhythmicity (p = 0.170 for the overall time effect; p = 0.101 for 
JTK_Cycle; Figure 6C). We therefore subsequently analyzed the other two PER-
isoforms PER1 and PER3 and found a strong rhythmic expression pattern (PER1: 
p < 0.001 for the overall time effect; JTK_Cycle p < 0.001; PER3 p < 0.001 for the 
overall time effect; JTK_Cycle p < 0.001; Figure 6F - 6G).
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Figure 6 – Core molecular clock gene expression in skeletal muscle. mRNA expression of 
BMAL1 (A), CLOCK (B), PER2 (C), CRY1 (D), REV-ERBa (E), PER1 (F), PER3 (G), combined 
expression pattern of PER1, PER2 and PER3 in one graph (H). For reference, we depicted 
the mRNA expression of the representative gene from our earlier study in young, 
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healthy, lean subjects [9] using dotted lines. Data are normalized to the geometric of 3 
housekeeping genes. The dark grey area represents the sleeping period (12AM - 7AM). 
Data is presented as mean ± SEM. * p < 0.05 for effect of time.
Discussion
We previously showed that skeletal muscle displays 24-h day-night rhythmicity 
in core molecular clock gene expression and mitochondrial oxidative capacity 
in young, healthy humans. This day-night rhythmicity was paralleled by day-
night rhythms in whole-body energy and substrate metabolism, including a 
typical feeding-fasting cycle of substrate oxidation [9]. Higher age, excess body 
fat and insulin resistance are all characteristic for reduced metabolic health 
and are typically associated with low skeletal muscle mitochondrial function 
[26; 27] and metabolic flexibility [28]. To the best of our knowledge, we here 
show for the first time in humans that skeletal muscle of older, metabolically 
comprised individuals is characterized by a lack of 24-h day-night rhythmicity 
in mitochondrial oxidative capacity and by disturbed molecular clock gene 
expression, paralleled by alterations in 24-h energy and substrate metabolism.
In the current study, mitochondrial oxidative capacity was determined in older, 
insulin resistant or glucose intolerant participants using an identical methodology 
as in several of our previous studies [18; 19; 29], allowing the comparison of the 
absolute values. Mitochondrial respiration rates were clearly lower as compared 
to a group of young, lean participants [9], thereby confirming previous results 
in a comparable, older pre-diabetic population [29]. More interestingly however, 
older, metabolically comprised participants did not show the 24-h day-night 
rhythmicity in mitochondrial respiration that we previously observed in young, 
lean, healthy volunteers (indicated with dotted lines in Figure 1 [9]). Thus, in our 
previous study mitochondrial oxidative capacity displayed a clear day-night 
rhythm with a peak in mitochondrial respiration at the end of active period 
and a trough at 1 PM [9]. In the current study however, lowest respiration 
occurred at 11 PM suggesting that the peak in mitochondrial respiration that is 
observed in the young lean participants is completely lost. This shows that the 
ability to adjust mitochondrial oxidative capacity over the 24-h day-night cycle 
is a characteristic feature of young, lean participants, which is lost in older, 
overweight participants. Interestingly, this finding was paralleled by a blunted 
metabolic flexibility as indicated by only a marginal variation in resting RQ over 
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the 24-h period (max variation in RQ over 24 hours: 0.05 in older, overweight 
versus 0.08 in young, lean, see dotted line in Figure 4B). This lack of oscillation 
in mitochondrial oxidative capacity throughout the 24-h day-night cycle suggests 
that restoration of circadian rhythmicity is a potentially interesting target to 
improve metabolic health. The mechanisms underlying the lack of day-night 
rhythmicity in mitochondrial function in older, overweight volunteers cannot be 
deduced from the current study and requires further investigation. Nonetheless, 
we found that the marker of mitochondrial fission FIS-1 protein was not 
rhythmic – contrary to our previously published data – suggesting that altered 
mitochondrial dynamics may play a role in the absence of rhythmic respiration 
[30; 31]. Interestingly, rhythmicity of FIS1 and PINK1 on the mRNA and protein 
in liver is dependent on BMAL1 [30]. We therefore measured expression of these 
mitochondrial dynamics markers to see if the lack of rhythmicity is also present 
on the mRNA level. We found that FIS-1 was borderline significant for a time 
effect (p = 0.052), while PINK-1 and BNIP-3 showed significant 24-h variation 
(PINK-1 p = 0.031; BNIP-3 p = 0.004). This discrepancy between rhythmicity on 
the mRNA and protein level might indicate that rhythmicity of FIS-1 and PINK-1 
protein levels is affected by a posttranscriptional mechanism [32].
In order to investigate if the lack of rhythmicity in mitochondrial oxidative 
capacity was due to a disturbed skeletal muscle circadian clock, we measured 
the core clock genes in skeletal muscle. Interestingly, the positive limb of the 
feedback loop (BMAL1 and CLOCK) was remarkably similar to our previous 
study with young, lean participants. Also, the clock gene REV-ERBa was 
expressed almost identically in both studies. Previous research in mice showed 
that knock out of REV-ERBa in skeletal muscle leads to reduced mitochondrial 
oxidative capacity and that overexpression might increase oxidative capacity 
[33]. The current results do not suggest that REV-ERBa is linked to the lack 
of rhythmicity in mitochondrial oxidative capacity in our older, overweight 
participants. Contrary to the positive limb of the feedback loop, expression of the 
negative regulator PER2 was not rhythmic in skeletal muscle. We also analyzed 
the expression of the other two isoforms of the PER gene family, PER1 and 
PER3, which did show rhythmic expression. This finding is interesting because 
in mice, knock out of PER2 leads to loss of rhythmic oxidative capacity [34]. 
Moreover, a recent study reported a pathway in which inflammation induced 
the transcription factor NF-κB, which directly repressed PER2 and CRY1 leading 
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to impaired rhythmicity in liver [35]. Thus, it is possible that aging, obesity and 
insulin resistance, which are associated with inflammation [36], may contribute 
to the observed impairment in clock gene expression. Whether the loss of rhythm 
in PER2 is specific to skeletal muscle tissue remains to be established and cannot 
be answered from the current study. However, a recent study reported that 
rhythmicity of PER2 expression in adipose tissue of both overweight T2DM 
patients and lean healthy controls was similar, suggesting that in adipose tissue 
PER2 expression is not altered [37].
In contrast to the lack of day-night rhythmicity in mitochondrial capacity, resting 
metabolic rate displayed a clear pattern over the 24-h day-night cycle with a peak 
in the late evening at 11PM. This rhythm is very similar to our previous study in 
which RMR displayed the same pattern and is in agreement with another study 
of a 24-h measurement in resting energy expenditure [38]. Whole body substrate 
oxidation changed during the day, with an increased relative carbohydrate 
oxidation and a lowered fat oxidation in the evening compared to the morning. 
The last meal was provided at 7 PM, but even several hours later (11 PM and 4 
AM) the RER had not decreased. This is in contrast to our findings in young, 
lean participants, even though composition of the meals was similar in the two 
studies and indicates metabolic inflexibility in the older, overweight and insulin 
resistant participants. A decrease in metabolic flexibility is typically observed in 
obesity [28], prediabetes [39], and diabetes [10], but is usually measured under 
fasting conditions in the morning or in the postprandial phase. In the present 
study we found that metabolic inflexibility persisted throughout the entire 24-h 
day-night cycle and especially in the sleeping period at night, suggesting that 
especially at night our participants did not enter in the typical fasted state. This 
observation is remarkable, as volunteers were fed in energy balance, suggesting 
that this lack of feeding-fasting cycle is a characteristic of these older, overweight 
participants.
The lack of a feeding-fasting cycle is further confirmed by the higher glucose, 
insulin and TG levels, as well as lower FFA levels after the breakfast and 
lunch in comparison to the lean, young participants from our previous study, 
again despite that participants were fed in energy balance in both studies. 
Despite insulin being ~60% higher 1 hour after breakfast in the current study, 
glucose also remained elevated in comparison to the young and lean group, 
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confirming the insulin resistant state of the participants in the current study. 
Interestingly, the glucose peak after the dinner was similar to the earlier study, 
but glucose levels only returned to fasting values at 2AM in the night (vs. 10 
PM in young, lean participants, Figure 5A), showing that despite higher insulin 
levels, glucose homeostasis was not reached until 6 hours after dinner. Whether 
this observation is only attributable to muscle insulin sensitivity or also due 
to blunted suppression of hepatic glucose production cannot be inferred from 
these data. Future studies could measure insulin signaling markers, such as 
phosphorylation status of AKT or AS160 in muscle biopsies taken around the 
clock. However, due to lack of muscle material this was not possible in the current 
study. Furthermore, FFA levels – substrates that are released from adipose tissue 
under fasting conditions – were high in the fasted state, but had a relatively 
small amplitude over the 24-h period compared to the profile of young and 
lean participants, again suggesting that in our older, overweight population the 
effect of fasting on substrate oxidation was attenuated. Elevated postprandial 
insulin levels may play a role herein, as insulin inhibits adipose tissue lipolysis 
[40]. Finally, triglyceride levels increased during the day and only started to 
decline after midnight at 12 AM. The increase in TG during the day might be 
explained in part by chylomicrons that enter the circulation postprandially. 
Indeed, also in the previous study, TG increased clearly after the dinner, which 
had the highest fat content of all meals (Figure 5D). However, compared to the 
lean, healthy volunteers, TG levels in the present study are consistently high 
and keep increasing until midnight, again in agreement with a prolonged fed 
state. An alternative mechanism underlying this observation might be increased 
hepatic VLDL-TG production that is stimulated by higher postprandial insulin 
levels in the insulin resistant state [41; 42].
This study does not come without limitations. The lack of a control group with 
similar age but normal weight or insulin sensitive prevents us from drawing 
conclusions whether aging, overweight or insulin resistance it responsible for 
the lack of rhythmicity. Furthermore, we only included Caucasian men in both 
our current and previous study and our findings need to be confirmed in a more 
diverse population.
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Conclusions
We show here that in older, metabolically comprised participants, mitochondrial 
oxidative capacity of skeletal muscle does not exhibit a day-night rhythm. 
Furthermore, we report that the rhythmicity of PER2, a member of the internal 
circadian clock is affected. Additional metabolic parameters demonstrate that 
features of metabolic inflexibility can be observed during over the full 24-h day-
night cycle and that older, insulin resistant participants do not enter a typical 
feeding-fasting cycle, even when fed in energy balance. Future studies are needed 
to explore strategies that can restore the day-night rhythm in mitochondrial 
oxidative capacity and substrate oxidation.
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Supplemental Figure 1 – Study design. Subjects stayed in a room of the metabolic 
research for a total of 44 hours. Meals were determined based on metabolic rate of the 
subjects: B, breakfast; L, lunch; D, dinner. M, measurement indicates timepoint of indirect 
calorimetry followed by muscle biopsy.
Supplemental Figure 2 – Core Body Temperature (CBT) during day of the study protocol. 
Temperature (°C) was recorded every 15 seconds and averaged per subject into 30 min 
bins. The dark grey area represents the sleeping period (12AM - 7AM). The characteristic 
drop in CBT beginning in the evening shows similar entrainment of the central circadian 
clock between subjects. Depicted is CBT mean ± SEM of n=11 subjects.
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Supplemental Figure 3 – Gene expression of mitochondrial dynamics markers in skeletal 
muscle. mRNA expression of FIS-1 (A), PINK-1 (B), BNIP3 (C). Data are normalized to the 
geometric of 3 housekeeping genes. The dark grey area represents the sleeping period 
(12AM - 7AM). Data is presented as mean ± SEM. * p < 0.05 for effect of time.
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Targeting deregulated nutrient sensing and mitochondrial 
dysfunction
In cellular metabolism, adenosine monophosphate-activated protein kinase 
(AMPK) and sirtuin 1 (SIRT1) are regarded as nutrient sensors, susceptible to 
changes in the energy status of the cell, which is reflected by the adenosine 
monophosphate (AMP) / adenosine triphosphate (ATP)-ratio and the nicotinamide 
adenine dinucleotide (NAD+)/NADH redox potential, respectively (1, 2). A high 
AMP/ATP-ratio and NAD+/NADH redox potential reflects a state of energy 
demand and invokes a response to optimize catabolic cellular metabolism. 
This response originates from AMPK and activates SIRT1 and its downstream 
targets peroxisome proliferator-activated receptor gamma coactivator-1-alpha 
(PCG-1α) and forkhead box protein O1 (FOXO1). These factors, in turn, elicit 
mitochondrial biogenesis and control carbohydrate and fatty acid oxidation, 
thereby, promoting mitochondrial function and overall metabolic health (3, 
4). The most straight-forward way to invoke a state of energy demand is by 
increasing energy expenditure through physical activity. Exercise extensively 
affects the human body, which will adapt acutely to maintain homeostasis and 
support the physical effort to the best of its ability. Repeated exercise bouts, i.e. 
exercise training, will invoke AMPK activation that promotes mitochondrial 
function (5) and metabolic health (6). Alternatively, caloric restriction (i.e. a ~20-
50% reduction of daily energy intake), is a proven physiological intervention 
known to promote lifespan in vivo by activating both AMPK and SIRT1, whilst 
improving overall health and negating age-dependent disease (7). Central to 
the activation of AMPK and SIRT1 is the NAD+/NADH redox potential and, 
therefore, influencing NAD+ metabolism poses as a prime target to elicit the 
downstream effects of this axis.
NAD+: the silver bullet that needs to be loaded into the right gun
It is generally accepted that NAD+ levels are a main regulator of mitochondrial 
function in skeletal muscle. Furthermore, SIRT activity is limited by NAD+ 
bioavailability (8), which is suggested to decline with increasing age in mice (9, 
10) and humans (11, 12). Hence, manipulating NAD+ levels represents a target 
for intervention to prevent the age-related decline in skeletal muscle physical 
function by improving metabolism and mitochondrial function. NAD+ can be 
Niels_Proefschrift.indd   204 08/12/2020   18:05:57
205
General Discussion
derived from various dietary sources as it can be synthesised de novo from the 
essential amino-acid L-tryptophan (Trp) or from vitamin B3 compounds such 
as nicotinic acid (NA, niacin) through the Preiss-Handler pathway or salvaged 
from nicotinamide (NAM) and nicotinamide riboside (NR) (13).
In Chapters 2 and 3, the potential of influencing the NAD+ metabolism in 
humans has been reviewed and investigated respectively in order to promote 
metabolic health and mitochondrial function. Whilst a number of studies agree 
with Chapter 3 in demonstrating that different exogenous NAD+-precursors can 
elevate NAD+ intermediates and/or metabolites such as methyl-nicotinamide 
(MeNAM) in vivo, no downstream effects on mitochondrial function have 
been observed in middle-aged to older adults who were normal to overweight 
(Chapter 3)(14, 15) and middle-aged to older, obese individuals (16, 17). However, 
improvements in skeletal muscle mitochondrial function have been observed 
in Acipimox – a synthetic NA-analogue – treated individuals with type 2 
diabetes mellitus (T2DM) (18). Interestingly, the polyphenol resveratrol, a direct 
stimulator of AMPK (19) and SIRT1 (20), has been shown to improve skeletal 
muscle mitochondrial respiration capacity in obese (21) and insulin resistant 
humans (22, 23). Moreover, the biguanide metformin, the predominant first-line 
pharmacological treatment for T2DM, also elicits improvements in mitochondrial 
function in a AMPK-dependent fashion (24) and promotes mitochondrial 
complex 1 respiration in individuals with T2DM (25). Together, there is evidence 
to support that pharmacological or nutraceutical targeting of the AMPK/
SIRT1-axis can mimic the effects on mitochondrial function seen upon caloric 
restriction or exercise interventions, but it does illustrate that NAD+-precursor 
supplementation efficacy on mitochondrial function is ambiguous in humans.
In Chapter 3, no improvements in mitochondrial function or physical function 
parameters were observed in physically compromised, older adults supplemented 
with NAD+-precursors. One possible explanation could be that these participants 
actually did not experience a decline in NAD+ levels. Alternatively, the 
supplementation doses of the various precursors used in Chapter 3 may have 
been insufficient to increase NAD+ levels. However, Elhassan et al. (14) also did 
not observe any alterations in mitochondrial respiration capacity, despite the 
fact that they supplemented healthy, older adults with 1000 mg of NR – a dose 
almost five times greater than the one used in Chapter 3. This suggests that 
7
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the dose used in Chapter 3 may not be the predominant reason behind the 
lack of downstream effects on mitochondrial function. In this context, Elhassan 
et al. (14) have proposed a ‘second hit’ theory, stating that NAD+ levels might 
only be susceptible to decline with age if combined with metabolic disease or 
physical inactivity leading to a reduction in NAD+ salvage through NAMPT or 
increased NAD+ consumption by CD38 and/or poly(ADP-ribose) polymerase 
(PARP). Hence, it is possible that the cohort of older adults in Chapter 3 is still 
too physically active for NAD+ levels to decline in the absence of additional 
metabolic disease, and therefore do not have reduced levels of NAD+. The 
degree of metabolic disruption needed to allow NAD+ levels to decline, and thus 
become susceptible to supplementation, is illustrated by the study of Pirinen et 
al. (26), who demonstrated the efficacy of niacin supplementation in improving 
mitochondrial function and increasing muscle mass in vitamin B3-deficient 
patients with mitochondrial myopathy; this in large contrast to the healthy 
control group who displayed unaffected mitochondrial function and muscle 
mass whilst receiving identical treatment.
The skeletal muscle NAD+ concentrations measured following supplementation with 
NAD+-precursors in Chapter 3 seem to be of similar magnitude when comparing 
with skeletal muscle NAD+ concentrations in healthy, obese individuals (16), admit 
a 5-fold difference in supplementation dose and population differences such as BMI 
and age. This study follows a similar pattern of unresponsiveness of skeletal muscle 
NAD+ levels to NR supplementation in healthy, older adults, as stated previously 
(14). The comparable NAD+ concentrations observed in Chapter 3 and the previous 
study in obese individuals (16) may suggest NAD+ levels to be at their homeostatic 
maximum, contributing to a lack of downstream effects following supplementation. 
Admittingly, NAD+ concentrations are known to decline with age under increased 
consumption by PARP and CD38 (12, 27), yet NAD+ resynthesis capacity can be 
restored through exercise through NAMPT induction (11).
With the NAD+ pool resulting from the balance between (re)synthesis and 
consumption (10, 28, 29), elevating NAD+ availability through supplementation 
alone could potentially be insufficient to influence downstream targets in the 
absence of (severe) disease. Thus, it is tempting to hypothesise that it may not be 
NAD+ levels per se that dictate downstream effects, but the overall flux of NAD+ (re)
synthesis and consumption. Therefore, based on the observations made in Chapters 
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3 and 4, it would be interesting as a next step to assess NAD+ concentrations in the 
skeletal muscle tissue acquired from young and older adults to determine whether 
NAD+ levels actually decline with age in tandem with a reduction in mitochondrial 
respiration capacity as observed in Chapter 4. Alternatively, the assessment of the 
NAD+/NADH redox potential and NAD(P)H metabolite concentrations through 
magnetic resonance spectroscopy (MRS) would allow for the study of NAD+ 
levels in vivo in real-time in a non-invasive manner (30), analogous to the 31P-MRS 
measurements in Chapters 4 and 6 to determine phosphocreatine kinetics during 
exercise recovery. Next, it would be of great interest to determine NAD+ levels in 
an age-matched cohort of older adults with differing levels of habitual physical 
activity (Chapter 4); is the homeostatic maximum of NAD+ constant irrespective 
of physical activity, or does the homeostatic maximum vary and reflect the 
metabolic profiles? If the later indeed turns out to be the case, strategies focussing 
on influencing the NAD+ metabolism may have to provide a greater flux of NAD+ 
(re)synthesis and consumption to achieve downstream benefits in mitochondrial 
function and metabolism.
To this end, Chapter 2 provides insight in alternative strategies which merit 
investigation in order to increase the potential of interventions focussing on 
NAD+ metabolism. One strategy with the potential to be greater than the sum of 
its parts is the combination of exercise and NAD+ supplementation (Chapter 2). 
Exercise is known to activate AMPK, which in turn increases the NAD+/NADH 
redox potential by elevating NAD+ levels through NAMPT induction (11, 31, 
32). Interestingly, VO2peak is a known predictor of NAMPT levels in young and 
older adults (11, 31), with NAMPT abundance shown to decline with age (11). 
In Chapter 4, VO2max declines with age and with decreasing levels of habitual 
physical activity amongst older adults, which may be suggestive of declining 
NAMPT levels. Moreover, VO2max correlates with mitochondrial function, the 
primary target of the NAD+-precursor supplementation in Chapter 3. Young 
adults demonstrated to have a higher mitochondrial oxidative capacity than 
older adults with similar levels of habitual physical activity, whereas trained 
older adults demonstrated a higher mitochondrial oxidative capacity than age-
matched adults with lower levels of habitual physical activity (Chapter 4). As 
such, with mitochondrial function being a downstream target of SIRT activation 
under the influence of NAD+ levels, NAMPT induction through exercise could 
elevate NAD+ levels and possibly improve mitochondrial function.
7
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NAMPT has been established as the rate-limiting enzyme in NAD+ resynthesis 
through the salvage pathways (33, 34), transforming NAM into nicotinamide 
mononucleotide (NMN), and has a reported low Km which was determined to be 
0.94 μM (33) and 1.24 μM (34) for NAM in two separate studies. The high affinity 
of NAMPT for NAM results in a rapid saturation of the enzymatic capacity 
of NAMPT in the presence of abundant NAM, with NAMPT duly becoming 
the bottleneck of the reaction. It is within reason to state that when substrate 
levels are sufficient to saturate the enzymatic capacity, increasing the substrate 
concentration will not yield a greater product concentration. At high levels, 
NAM is also known to inhibit SIRT1 activity (35, 36). Hence, increasing enzyme 
availability alongside increased substrate concentrations would allow for the 
flux through the reaction to be lifted to a higher plain. This, in theory, could 
yield elevated product concentrations over baseline, which in this case yields 
higher NMN concentrations from NAM, to be converted into NAD+, allowing 
for a greater degree of consumption by SIRT1 and increasing its activation and 
eliciting downstream benefits.
Interestingly, SIRT, NAD+, and NAMPT are also known to form the enzymatic 
feedback loop of the molecular clock, thus interventions focussing on NAD+ 
metabolism may also benefit the function of the molecular clock as an integral 
controller of metabolism and will be discussed further on.
Use it, or lose it?
Frailty and sarcopenia are closely related (37) and both characterised by 
reduced physical function and overall low physical activity levels, which in turn 
contributes to the development of obesity and the progressive loss of muscle 
mass; ultimately initiating a vicious cycle of decline aggravating the process 
of ageing. Fortunately, both frailty and sarcopenia are reversible to a certain 
degree but require dedicated intervention to accomplish this. Skeletal muscle 
is generally accepted as one of the most plastic tissues in the human body, with 
an acute ability to adapt to differing contractile activity, loading conditions, 
substrate supply, or environmental factors (38).
In Chapter 4, a group of young adults and three groups of older adults with 
differing levels of habitual physical activity, notably in terms of intensity of 
Niels_Proefschrift.indd   208 08/12/2020   18:05:57
209
General Discussion
the physical activity performed, were cross-sectionally assessed. Interestingly, 
young and older adults with similar levels of physical activity – both groups 
managed approximately 10,000 steps a day – demonstrated to have similar levels 
of muscle mass but differed in mitochondrial function, muscle strength, and 
trended towards a difference in insulin sensitivity. Classical physiology teaches 
us to ‘use it or lose it’ regarding muscle mass. As such, it has been repeatedly 
demonstrated that immobilisation causes muscle atrophy (39), which is reversible 
upon reinstation of muscle loading (40), even at older age (41). The disuse of 
skeletal muscle through unloading in mice (42) and in humans (43) is known to 
induce a state of anabolic resistance, which is difficult to abate through anabolic 
stimuli in the early phase of recovery, in addition to an absence in restoration 
of insulin sensitivity and mitochondrial oxidative capacity (42). In Chapter 4, 
no statistically significant differences were observed in skeletal muscle mass 
between the young and old, or between the older adults with differing levels of 
habitual physical activity. This unexpected finding could be explained by lower 
levels of habitual physical activity are sufficient to maintain muscle mass, whilst 
experiencing dynapenia at older age; or the included cohort of older adults were 
not old enough to experience greater loss of muscle mass.
Chapter 4 provides evidence supporting the notion that higher levels of physical 
activity profoundly negate the effects of ageing on skeletal muscle function and 
mitochondrial function, which are also reflected by increased insulin sensitivity 
and a more favourable body composition; with a lower percentage of overweight 
or obese participants observed amongst the trained older adults compared to 
the normal and inactive older adults included in this study. The trained older 
adults in Chapter 4 are predominantly aerobically trained individuals, thus 
corroborating previous findings that a 6-month exercise intervention of aerobic 
exercise alone or combined with resistance exercise significantly improves 
insulin sensitivity in older adults (44). In addition to a large body of evidence 
pointing in the direction of the beneficial effects of physical activity or exercise 
training to maintain skeletal muscle mass and skeletal muscle function while 
aging (45), a greater gait stability and perturbation recovery amongst the trained 
older adults compared to normally active older adults is now added (Chapter 
4). Moreover, clear differences in measures of mitochondrial oxidative capacity 
amongst the three older adult groups were observed, parameters that strongly 
correlated with muscle strength and daily step count, respectively.
7
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Recently, daily step count has been associated with all-cause mortality 
irrespective of age, with especially individuals over the age of 65 benefitting from 
marked reductions in all-cause mortality with increasing daily step count (46). 
In Chapter 4, positive associations between in and ex vivo measures of skeletal 
muscle mitochondrial oxidative capacity and daily step count were observed 
irrespective of age, sex, and BMI. Taken from this, the ability to walk, may alone, 
provide great individual and populational health gains by maintaining skeletal 
muscle mitochondrial function.
Collectively, the observations in Chapter 4 illustrate the beneficial effect of 
increased physical activity or exercise training as an important parameter of 
metabolic health, emphasising the need to stay or become (more) physically active 
with advancing age, as maintaining skeletal muscle mass and function can slow 
or abate the onset of the vicious cycle of decline and promote healthy ageing.
Rewinding the clock
It was previously established that mitochondrial respiratory capacity is rhythmic 
in conjunction with the day-night cycle in young, healthy male individuals (47). 
In Chapter 4, a decline in mitochondrial respiration capacity in the older adults 
compared to the young was observed. This finding poses the question whether 
the loss of mitochondrial respiration capacity could be also related to a loss of 
rhythmicity. Indeed, Chapter 5 revealed a lack of rhythmicity in skeletal muscle 
mitochondrial respiration capacity in older, insulin resistant individuals.
Besides regulating cellular metabolism, SIRT1 is also known to be essential 
in the transcription and deacetylation of the core-clock components BMAL1 
(48), CLOCK (48), and period circadian protein homolog 2 (Per2) (49). Interestingly, 
Per2 gene transcription proved to be non-rhythmic in older, insulin resistant 
volunteers in Chapter 5, suggesting the involvement of SIRT1 and NAD+ within 
the loss of rhythmicity seen in this negative regulator of the molecular clock. 
Previously, mutations in Per2 resulted in decreased complex I activity, the site of 
NADH oxidation into NAD+, yielding a low NAD+/NADH redox potential (50). 
Additionally, NAD+ (51, 52) and NADH (53) levels are known to both display 
oscillating rhythms, reflecting the interplay of SIRT1 and NAMPT under the 
control of the molecular clock components (51, 52). Although Chapter 3 did not 
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reveal a change in mitochondrial respiration capacity or NAD+ levels following 
supplementation with NAD+-precursors, it should be noted that mitochondrial 
function and NAD+ were only measured at one time point in the day, thus 
prohibiting the assessment of circadian oscillations in these parameters; if 
these are even still present in older, insulin-resistant individuals, a question that 
deserves further research on its own merit. Interestingly, a recent study in mice 
found that increasing NAD+ levels through supplementation in aged mice can 
restore rhythmicity of clock gene transcription and mitochondrial respiration, 
with the animals also becoming more physically active (54). It is within reason 
to state that circadian oscillations of NAD+ govern SIRT1, and thereby, induce 
rhythmicity of mitochondrial respiration capacity in conjunction with the day-
night cycle as seen in young, healthy males (47), thus suggesting that influencing 
the NAD+ metabolism flux in humans may be a modality through which clock 
and mitochondrial rhythmicity can be restored.
The loss of rhythmicity in mitochondrial metabolism in Chapter 5 is paralleled 
by 24-hour metabolic inflexibility, the inability to align substrate utilization 
to the energy demand and substrate availability, resulting in the absence of a 
normal feeding-fasting cycle in spite of being fed in energy balance. This result 
implicates the presence of metabolic inflexibility over 24-hours to be an intrinsic 
characteristic of insulin resistance, a finding that may be transferable to metabolic 
inflexibility observed previously in obesity (55) and T2DM (56). Moreover, these 
observations are in line with the hypothesis by Canto et al. (4) in 2009, proposing 
defects in mitochondrial oxidative function and the subsequent decrease in energy 
expenditure contribute to metabolic dysfunctions as seen in insulin resistance, 
T2DM, and ageing. The BMR and mitochondrial respiration capacity observed in 
Chapter 5 are lower when comparing the insulin resistant cohort to the reference 
of the young, healthy cohort (47). However, it is impossible to contribute this 
decline to either ageing, insulin resistance, or a combination of the two.
With multiple components of the transcription feedback loop being governed by 
the activity of the nutrient sensors AMPK and SIRT1, it is tempting to consider 
a combined intervention of exercise and NAD+ supplementation aiming to 
improve nutrient sensing and mitochondrial function to combat dysfunction 
of the molecular clock and potentially restore rhythmicity to mitochondrial 
metabolism and improve substrate utilization.
7




Recruitment of brown adipose tissue (BAT) has been proposed as a potential 
strategy to increase daily energy expenditure to combat the development of 
obesity. A number of strategies have been pursued aiming at inducing non-
shivering thermogenesis (NST) in BAT through the sympathetic nervous system, 
e.g. pharmacological targeting of BAT with Mirabegron (a selective β3-receptor 
agonist), via (acute) cold exposure (57) or high-energy intake (58). Conversely, 
declining BAT abundancy and activity with increasing age and BMI (59, 60) 
prohibit the implementation of BAT-centric interventions despite promising 
preclinical studies in the wake of the societal obesity and ageing challenges. 
Additionally, the fundamental difference in reliance on BAT functionality in 
small mammals compared to the situation in humans must be considered (61), 
even though the evolutionary conservancy of BAT across species is likely driven 
by a need to maintain core body temperature when exposed to cold, but not to 
burn off excess caloric intake (62). Nevertheless, a newly discovered creatine-
driven substrate cycle that supports thermogenesis in murine beige adipocytes 
(63) opens up a new avenue to exploit the potential of NST in humans.
Two retrospective studies of BAT activation in humans concluded that BAT 
activation is observed most in females and in younger, leaner individuals (64, 65). 
In chapter 6, young, healthy, lean and mostly female individuals who adhered to 
a vegetarian diet were included, as these individuals present a high probability 
of detecting and recruiting BAT and are prone to have a healthy, yet low, creatine 
availability status (66-69). Although preclinical research has suggested a role for 
creatine in BAT thermogenesis (70-72), no effects of creatine supplementation 
on diet-induced thermogenesis or BAT activation in healthy, lean vegetarians 
were reported (Chapter 6). In retrospect, the results presented in Chapter 6 
are in agreement with preclinical findings to date, which demonstrated that 
differing levels of creatine abundance alone does not reconstitute impairments 
in diet-induced thermogenesis or β-adrenergic stimulated energy expenditure 
(71, 72). The thermogenic effect of the creatine-driven substrate cycle in 
mice only prevails when the following three conditions are met: 1) creatine 
abundance, 2) high-fat diet, and 3) β-adrenergic stimulation (72). In wild-type 
mice fed a high-fat diet, dietary creatine supplementation yielded higher acute 
β3-adrenergic agonist-dependent energy expenditure in comparison with 
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non-supplemented littermates, suggesting a possible interaction between the 
creatine supplementation and high-fat diet or an increase in creatine uptake 
by BAT, or a combination of these two factors (72). The approach taken did not 
include the high-fat diet component, suggesting its necessity for the efficacy of 
the pathway as recently seen in mice (72). Thus Chapter 6 raises the question 
whether the lack of reproduction of the preclinical findings (71, 72) in humans 
comes down to a difference in physiology between mouse and man, or, that 
the selection of young, healthy, lean individuals does not represent the target 
population for BAT-centric intervention due to a lack of potential metabolic 
improvement and the lack of the high-fat diet component or challenge, in spite 
of a large window of opportunity considering creatine availability. Moreover, 
Kazak et al. has demonstrated creatine transporter (CRT) expression in WAT 
to be negatively correlated with obesity and insulin resistance in humans (72), 
suggesting a relationship between creatine transport and the development of 
obesity. Interestingly, insulin resistant individuals could be devided in low or 
high CRT expresion subgroups, with the low CRT expression subgroup having 
a higher BMI than the high CRT expression subgroup (72), thus meriting further 
investigation into the role creatine in human physiology.
Traditionally, creatine is used as an ergogenic aid to enhance exercise 
performance (73, 74), by increasing skeletal muscle creatine and phosphocreatine 
(PCr) concentrations (74, 75) and positively influencing the PCr recovery rate 
(76), ultimately enhancing the resynthesis of ATP to support the exercise effort. 
PCr recovery is a non-invasive in vivo measure of mitochondrial function, and 
although no changes in PCr recovery rate or ex vivo mitochondrial respiration 
capacity in healthy lean individuals were observed in Chapter 6 following 
creatine supplementation, lower PCr recovery rates are seen with insulin 
resistance (77), corresponding to lower ex vivo mitochondrial respiration capacity 
(22, 78). Creatine supplementation has been credited with hypoglycaemic effects 
in humans, especially when combined with an exercise intervention (79). 
However, evidence concerning the effect of creatine supplementation on insulin 
sensitivity, especially in T2DM individuals, is scarce and merits additional 
investigation in its own right. The use of creatine as an ergogenic supplement 
is a safe modality to support exercise efforts (80) and could elevate the efficacy 
of exercise interventions aiming to secure (long-term) weight loss and, thereby, 
improve metabolic health.
7




The aim of this thesis is to identify and investigate novel targets to promote 
healthy ageing by improving metabolic health. As stated in Chapter 2, NAD+ 
supplementation may require a combined approach with another intervention to 
extract its full potential, as supplementation with NAD+-precursors alone did not 
improve mitochondrial function (Chapter 3). Chapter 4 provides clear evidence 
that exercise at advanced age is beneficial for maintaining overall metabolic 
health and physical performance. Therefore, it remains to be elucidated whether 
NAD+ supplementation as an add-on therapy to an exercise intervention would 
have synergistic effects by promoting exercise tolerance, mitochondrial function, 
and physical function to a greater extent than exercise alone in older adults in the 
absence of metabolic disease. Coincidingly, individuals with metabolic disease 
such as T2DM would potentially be more susceptible to the rebalancing of the 
nutrient sensing pathways through NAD+-precursor supplementation alone or 
combined with exercise.
Under the notion that the NAD+ consumers and NAD+ itself reciprocally 
regulate the molecular clock components (81), the decline of NAD+ reported 
with aging may be a factor in the loss of rhythmicity in mitochondrial function 
and components of the molecular clock, as found in Chapter 5. However, as the 
volunteers were affected by a combination of obesity, insulin resistance, and 
advanced age, it is impossible to distinguish what role each of these components 
plays in the loss of rhythmicity. Therefore, it is recommended to conduct 
additional trials using a similar design to assess mitochondrial rhythmicity 
and the functionality of the core clock components in healthy, older adults to 
elucidate the effect of ageing on the molecular clock specifically. In the event 
that ageing indeed contributes to loss of rhythmicity, it would be interesting 
to subsequently assess strategies aiming to restore the rhythm, which could be 
done though an exercise intervention, NAD+ supplementation, or a combined 
approach.
The harnessing of NST as a strategy to combat obesity remains an intriguing 
prospect but requires additional research to elucidate the true therapeutic potential 
in humans. With the recent discovery that the β2-adrenergic receptor is responsible 
for BAT activation in humans (82), future research can take advantage of targeted 
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pharmacological stimulation of BAT using specific β2-agonists. Moreover, a series 
of preclinical studies revealed a creatine-driven substrate cycle that is capable 
of producing heat in murine beige adipocytes. Although no effects of creatine 
supplementation on BAT activation or diet-induced thermogenesis were observed 
in Chapter 6, the role of creatine abundance in NST in humans requires further 
investigation to be fully elucidated. Additionally, it must be kept in mind that 
following a lower probability of detecting and activating BAT in obese individuals 
will require larger trails to attain sufficient power to allow reliable conclusions to 
be drawn. It is, therefore, recommended to further research into the role of creatine 
abundance in energy balance in humans, emphasising on metabolic impairment 
as seen in overweight and obese individuals in order to elucidate the potential 
efficacy of this mechanism to aid in the combat of obesity.
Concluding remarks
In order to find translation to everyday practice, interventions aiming to promote 
healthspan by improving metabolic health will require a dedicated approach 
which must be sustainable to allow for long-term adherence and compliance. 
Illustrated by the contents of this thesis, one cannot solely rely on the use 
of supplements to negate deregulated nutrient sensing and mitochondrial 
dysfunction, as the importance of physical activity and the role of the molecular 
clock within metabolic health must be factored in; thus warranting the use of 
combined approaches to elicit the maximal potential of the chosen intervention. 
Through improving and maintaining physical function and reducing obesity, our 
biological age can be positively influenced, and simultaneously, maintain and 
improve skeletal muscle mitochondrial function and overall metabolic health, 
and ultimately, prolong healthspan in humans.
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Wat is het doel van het onderzoeken in dit proefschrift en wat 
zijn de belangrijkste conclusies?
Met een goede stofwisseling word je gezonder ouder, is de algemene gedachte. 
Het doel van dit proefschrift is om nieuwe aanknopingspunten te vinden 
om de stofwisseling van de (oudere) mens te verbeteren. In de cellen van het 
menselijk lichaam zitten energiecentrales die mitochondriën worden genoemd. 
Een manier om de werking van de mitochondriën, en daarmee de stofwisseling, 
te verbeteren, is met behulp van een stof die NAD+ wordt genoemd. NAD+ is een 
stof die in de mitochondriën nodig is om energie op te wekken. Om meer NAD+ 
in de mitochondriën aan te maken is vitamine B3 nodig. Door het innemen 
van extra vitamine B3 kan de hoeveelheid NAD+ in de mitochondriën worden 
verhoogd, waardoor de mitochondriën mogelijk beter werken. Op deze manier 
kan de stofwisseling verbeterd worden.
In Hoofdstuk 2 is een literatuurstudie gedaan naar het effect van het innemen 
van extra vitamine B3 op de stofwisseling in mensen. Het innemen van extra 
vitamine B3 alléén blijkt niet genoeg om de stofwisseling te verbeteren. Als het 
innemen van extra vitamine B3 samengaat met regelmatig sporten, dan kan extra 
vitamine B3 innemen misschien wel de stofwisseling verbeteren.
We weten dat de hoeveelheid NAD+ in de mitochondriën minder wordt met het 
ouder worden. Dit roept de vraag op of het innemen van extra vitamine B3 door 
oudere mensen kan zorgen voor een betere stofwisseling?
In Hoofdstuk 3 is dit idee verder onderzocht. Een groep oudere mensen 
consumeerde een maand lang extra vitamine B3. Vervolgens is de werking van 
de mitochondriën in de spieren van deze oudere mensen onderzocht. Deze 
mitochondriën bleken echter niet beter te functioneren na het innemen van extra 
vitamine B3.
In Hoofdstuk 4 is onderzocht of regelmatig sporten bepaalde effecten van ouder 
worden kan tegengaan. Allereerst is een groep oudere mensen vergeleken met 
een groep jonge volwassenen. Hieruit bleek dat de werking van de mitochondriën 
in de spieren van oudere mensen inderdaad slechter is dan die van jonge mensen. 
Ook zijn verschillende groepen oudere mensen, die veel of weinig sporten, 
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onderzocht met betrekking tot de werking van de mitochondriën in de spieren 
en de spieren zelf. Door deze groepen met elkaar te vergelijken is onderzocht wat 
het effect is van lichaamsbeweging op hogere leeftijd. Met regelmatig sporten 
op hogere leeftijd kan worden voorkomen dat de werking van de mitochondriën 
minder wordt. Het veelvuldig (intensief) blijven bewegen op hogere leeftijd is 
dus goed voor het onderhouden van de gezondheid van de stofwisseling en de 
werking van de mitochondriën.
Ook het dag-nacht ritme is heel belangrijk voor het goed werken van de 
stofwisseling en het voorkómen van bijvoorbeeld suikerziekte. Onderzoek 
in jonge mensen heeft laten zien dat ook de mitochondriën een dag-nacht 
ritme hebben. In Hoofdstuk 5 is onderzocht of het dag-nacht ritme van de 
mitochondriën nog aanwezig is bij een groep oudere mannen, die vanwege 
overgewicht een groter risico hebben op het krijgen van suikerziekte. De werking 
van de mitochondriën in de spieren is onderzocht op vijf momenten verspreid 
over één dag en nacht (24 uur). Hieruit bleek dat het dag-nacht ritme van de 
mitochondriën van deze groep oudere mannen met overgewicht verstoord was. 
Maar wat is daar de reden van? Het overgewicht? De hogere leeftijd? Of een 
combinatie van deze factoren? Meer onderzoek is nodig om deze vraag te kunnen 
beantwoorden. Mogelijk leidt dit tot nieuwe inzichten om het dag-nacht ritme 
van de mitochondriën te herstellen.
Tijdens het ouder worden neemt de kans op het krijgen van overgewicht toe. 
Overgewicht geeft een groter risico op het krijgen van ziekten zoals kanker, 
suikerziekte en/of hart- en vaatziekten. Daarom is het belangrijk om te voorkomen 
dat mensen overgewicht krijgen. Een van de manieren is ervoor te zorgen 
dat we meer energie gebruiken dan dat we innemen. Het actief maken van 
bruin vet kan hiervoor zorgen. Bruin vet is een speciaal soort vet dat heel veel 
mitochondriën bevat. Mitochondriën in bruin vet zijn bijzonder omdat ze energie 
kunnen omzetten in warmte. Dit kan worden vergeleken met een straalkachel 
die elektriciteit omzet in warmte. Als bruin vet veel warmte gaat maken ga je 
dus meer energie gebruiken waardoor je mogelijk kunt afvallen.
In muizen met overgewicht kan het stofje creatine ervoor zorgen dat bruin vet 
actiever wordt waardoor het helpt bij het voorkomen van overgewicht. Het is 
alleen nog niet bekend of dit in mensen ook zo werkt. Daarom is in Hoofdstuk 
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6 onderzocht of het innemen van extra creatine het bruin vet in mensen actiever 
maakt. Een groep jonge volwassenen kreeg negen dagen lang extra creatine 
om in te nemen. Na deze negen dagen is gemeten of het bruin vet actiever 
was geworden. De extra creatine zorgde er niet voor dat het bruin vet actiever 
werd in deze groep volwassenen. In tegensteling tot de muizenstudies, hadden 
de deelnemers aan het onderzoek geen overgewicht. Daarom moet er verder 
onderzoek worden gedaan in mensen met overgewicht om uit te zoeken of 
het innemen van extra creatine bij mensen met overgewicht het bruin vet wel 
actiever maakt en zo bij te dragen aan het voorkomen van overgewicht.
Wat is de bijdrage van de resultaten aan de wetenschap en 
maatschappelijke uitdagingen?
De resultaten van de onderzoeken die in dit proefschrift worden beschreven 
dragen bij aan de bestaande kennis die we hebben over de werking en de 
gezondheid van de stofwisseling van de mens. Met deze nieuwe kennis is er 
weer een nieuw puzzelstukje bijgekomen waarmee ons begrip van werking 
van de stofwisseling verder uitbreidt. Uit de onderzoeken kunnen nieuwe 
ideeën ontstaan voor onderzoeken waarmee nieuwe en betere manieren 
kunnen worden gevonden om mensen te helpen gezond ouder te worden. 
Ook kunnen de resultaten worden gebruikt door bijvoorbeeld overheids- of 
gezondheidszorginstanties om adviezen op te stellen hoe het aanpassen van de 
leefwijze kan helpen gezonder ouder te worden.
Mensen worden namelijk steeds ouder en er zijn steeds meer ouderen in 
verhouding tot het aantal jongeren. Dit fenomeen wordt ‘vergrijzing’ genoemd. 
Het omgaan met de vergrijzing is een grote maatschappelijke uitdaging, omdat 
de kans op het krijgen van een ziekte groter is met het ouder worden. Ziektes 
zoals suikerziekte, kanker en hart- en vaatziekten hebben een grote invloed op 
het leven en gezondheid van mensen. Ook dragen deze ziektes fors bij aan de 
stijgende kosten van de gezondheidszorg. Om de gezondheidszorg betaalbaar en 
de kwaliteit van leven goed te houden is het dus belangrijk dat mensen gezonder 
oud(er) worden.
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Voor wie zijn de onderzoeksresultaten interessant en relevant?
De resultaten van de onderzoeken in dit proefschrift zijn voor verschillende 
groepen mensen interessant. Als eerste voor onderzoekers, omdat de resultaten 
van de onderzoeken bijdragen aan het beter leren begrijpen hoe de stofwisseling 
van de mens werkt en hoe deze verandert als we ouder worden. Met deze kennis 
kunnen onderzoekers nieuwe ideeën gaan onderzoeken met als doel om steeds 
betere manieren te vinden om gezond oud(er) te worden. Als tweede zijn de 
resultaten interessant voor de gezondheidszorg. Zo kan er beter advies en uitleg 
worden gegeven worden aan patiënten over het hoe en waarom van goede 
voeding, het nut van blijven bewegen, en waarom het hebben van een gezond 
gewicht en een goed dag-nacht ritme belangrijk zijn voor een goed werkende 
stofwisseling én om deze te behouden. Ook kan de overheid de resultaten 
gebruiken om nieuwe, algemene adviezen te maken voor (oudere) mensen over 
de manier waarop zij leven en hoeveel zij bewegen. Als laatste zijn de resultaten 
van deze onderzoeken van belang voor iedereen in de samenleving. Iedereen 
wil oud worden, maar gezond oud worden draagt enorm bij aan een betere 
kwaliteit van leven.
De resultaten van de onderzoeken zijn beschreven in een aantal artikelen die 
met het publiek worden gedeeld in tijdschriften, op websites en op sociale 
media zoals Facebook of Twitter. Ook worden de resultaten van de onderzoeken 
gepresenteerd op landelijke en internationale bijeenkomsten met lezingen waar 
andere onderzoekers aanwezig zijn. Als laatste kunnen de resultaten worden 
gebruikt voor het onderwijs aan studenten of om lezingen voor het algemene 
publiek te maken.
A
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Het bevorderen van gezond ouder worden
Het nastreven van metabole gezondheid door middel van 
voedingsinterventie, fysieke activiteit en de biologische klok
Relevantie
Gedurende de afgelopen 200 jaar is de wereldwijde levensverwachting van 
de mens fors gestegen. Deze stijging is het gevolg van het implementeren van 
hygiëne maatregelen, de voortdurende vooruitgang van de gezondheidszorg 
en de verkrijgbaarheid van betere voeding. Tegelijkertijd neemt binnen de 
bevolking het aandeel ouderen boven de 65 jaar gestaag toe als gevolg van de 
stijgende levensverwachting. Dit wordt ook wel ‘vergrijzing’ genoemd. Met een 
hogere leeftijd wordt de kwaliteit van leven echter ook (negatief) beïnvloed. Er 
is namelijk een verhoogd risico op morbiditeit met gevorderde leeftijd als gevolg 
van niet-overdraagbare ziekten zoals diabetes mellitus type 2 (T2DM), hart- 
en vaatziekten, maligniteiten en degeneratieve ziekten. Deze ziektebeelden zijn 
dominant vertegenwoordigd in de lijst van de belangrijkste oorzaken van sterfte. 
Samen zorgen de stijging van de levensverwachting, de verandering van de 
demografische samenstelling door de vergrijzing én de chronische aard van niet-
overdraagbare ziekten voor een toename van de sociaaleconomische belasting 
van de maatschappij. Deze toenemende belasting rechtvaardigt daarom een 
verschuiving in het denken van het nastreven van een langere levensduur naar 
het verbeteren van de gezondheidsduur.
Doel van het proefschrift
In dit proefschrift ligt de focus op het aanpakken van twee kenmerken 
van veroudering, namelijk de mitochondriële disfunctie en de ontregelde 
energiestatus van de cel. Het doel van dit proefschrift is deze twee kenmerken 
van veroudering te beïnvloeden en zo nieuwe doelen te identificeren en te 
onderzoeken die het gezond ouder worden kunnen bevorderen door het 
verbeteren van de metabole gezondheid.
De enzymen adenosinemonofosfaat-geactiveerde proteïnekinase (AMPK) 
en sirtuin 1 (SIRT1) worden beschouwd als sensoren die gevoelig zijn voor 
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veranderingen in het energieniveau van de cel. De energiestatus van een cel 
wordt weerspiegeld door de verhouding tussen adenosinemonofosfaat (AMP) en 
adenosinetrifosfaat (ATP) en door de redoxpotentiaal van nicotinamide-adenine-
dinucleotide (NAD+) en NADH. Een hoge verhouding tussen AMP en ATP of 
een hoge redoxpotentiaal van NAD+/NADH weerspiegelt een tekort aan energie 
en roept een reactie op om het katabole cellulaire metabolisme te optimaliseren. 
Deze reactie is afkomstig van AMPK die vervolgens SIRT1 activeert, die op zijn 
beurt peroxisoom-proliferator-geactiveerde receptor gamma-co-activator-1-alfa 
(PCG-1α) en forkhead box proteïne O1 (FOXO1) activeert. Deze factoren zorgen 
voor de aanmaak van nieuwe mitochondriën, ook wel mitochondriële biogenese 
genoemd, en coördineren de verbranding van koolhydraten en vetzuren, 
waardoor de mitochondriële functie en de algehele metabole gezondheid worden 
bevorderd.
De redoxpotentiaal van NAD+/NADH speelt een centrale rol bij de activering 
van AMPK en SIRT1. Daarom is het beïnvloeden van het NAD+ metabolisme een 
belangrijk doelwit om de gunstige gezondheidseffecten van de AMPK/SIRT1-as 
op te wekken.
In Hoofdstuk 2 wordt de beschikbare literatuur over de effectiviteit van 
het beïnvloeden van het NAD+ metabolisme bij de mens bestudeerd met 
als doel het identificeren van strategieën om de metabole gezondheid in 
mensen te verbeteren. Deze evaluatie leidt tot de volgende conclusies: 1) 
lichaamsbeweging en calorische restrictie versterken de expressie van 
nicotinamide-fosforibosyltransferase (NAMPT) en waardoor de NAD+ niveaus 
toenemen; 2) NAD+-precursoren kunnen de NAD+ spiegels verhogen en worden 
over het algemeen goed verdragen door de mens, vooral in de vorm van 
nicotinamide riboside; 3) klinische humane interventiestudies die de impact 
van CD38-remmers, poly(ADP-ribose) polymerase-1-remmers of L-tryptofaan 
hebben onderzocht op de beschikbaarheid van NAD+ ontbreken vooralsnog; 
en 4) er wordt nog steeds reikhalzend uitgekeken naar overtuigend bewijs dat 
het verhogen van de NAD+ spiegels metabole stoornissen is de mens kunnen 
herstellen.
Op basis van de literatuurstudie in Hoofdstuk 2 lijkt de suppletie van NAD+-
precursoren via de voeding een manier om het gezond ouder worden te bevorderen 
A
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en de leeftijdsafhankelijke achteruitgang van skeletspiermassa en functie tegen 
te gaan. Om dit te onderzoeken is in Hoofdstuk 3 het effect van suppletie met 
NAD+-precursoren op de mitochondriële functie van de skeletspieren onderzocht 
in veertien fysiek beperkte ouderen in een gerandomiseerde en gecontroleerde 
klinische studie. De deelnemers hebben gedurende 32 dagen 207.5 mg NAD+-
precursoren (bestaande uit L-tryptofaan, nicotinezuur en nicotinamide) als 
supplement ingenomen, of er is een controlemiddel ingenomen zonder de NAD+-
precursoren. Alle deelnemers hebben beide periodes doorlopen waarbij niet 
bekend was in welke volgorde zij de supplementen ontvingen. De resultaten 
laten zien dat hoewel de NAD+ concentraties in de skeletspier niet significant 
verschillend bleken in vergelijking met de controleconditie, de concentratie van 
het afbraakproduct methyl-nicotinamide significant hoger was na suppletie 
met NAD+-precursoren. Dit resultaat wijst mogelijk op een verhoogd NAD+ 
metabolisme. Omgekeerd verbeterde de mitochondriële respiratiecapaciteit niet 
door suppletie met NAD+-precursoren. Ook de efficiëntie voor het leveren van 
inspanning was niet veranderd na suppletie met NAD+-precursoren. Daarmee 
zijn deze bevindingen in overeenstemming met eerdere bevindingen over de 
werkzaamheid NAD+-precursoren in mensen. NAD+ suppletie door middel 
van L-tryptofaan, nicotinezuur en nicotinamide verhoogt dus de methyl-
nicotinamide niveaus in skeletspierweefsel, maar verbetert de mitochondriële 
functie en skeletspierfunctie niet in fysiek beperkte ouderen.
De relatie tussen de leeftijdsgebonden achteruitgang van de mitochondriële 
functie en het effect hiervan op de werking van de skeletspieren is nog niet 
helemaal duidelijk. De leeftijdsgebonden afname van de mitochondriële capaciteit 
is mogelijk te wijten aan veroudering, maar kan ook worden verklaard door een 
leeftijdsgebonden afname van fysieke activiteit. Hoofdstuk 4 brengt in kaart 
in welke mate fysieke activiteit bijdraagt  aan de afname van de mitochondriële 
functie en spiergezondheid tijdens het verouderingsproces. Dit werd bestudeerd 
door middel van een gedetailleerde metabole fenotypering van 59 personen met 
verschillende niveaus aan fysieke activiteit variërend van kwetsbare ouderen 
tot atleten op leeftijd, en gezonde jonge volwassen die als controle golden. Het 
vergelijken van deze groepen laat zien dat veroudering geassocieerd is met een 
afname van de mitochondriële capaciteit, inspanningscapaciteit en -efficiëntie, 
loopstabiliteit, spierfunctie en insulinegevoeligheid. Bovendien kan een hoger 
niveau van fysieke activiteit door regelmatige inspanning de effecten van 
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veroudering gedeeltelijk tegengaan. Deze resultaten ondersteunen het idee dat 
de mitochondriën een therapeutisch doelwit zijn om de achteruitgang van de 
gezondheid van skeletspieren door veroudering tegen te gaan en om de fysieke 
functie en prestaties van de skeletspieren te kunnen behouden.
Het is bekend dat het 24-uurs ritme van het metabolisme betrokken is bij de 
ontwikkeling van leeftijdsgebonden metabole stoornissen. Recent is aangetoond 
dat de mitochondriële functie van de skeletspieren en het energiemetabolisme 
een dag-nachtritme vertonen in gezonde jonge mannen. Of het dag-nachtritme 
in de mitochondriële functie van de skeletspieren en het energiemetabolisme 
veranderd is in ouderen met metabole stoornissen is nog onbekend. In 
Hoofdstuk 5 is onderzocht of het ritme van de mitochondriële functie van de 
skeletspieren is veranderd in een groep van twaalf mannen van middelbare tot 
oudere leeftijd met overgewicht en insulineresistentie door middel van een reeks 
skeletspierbiopten verspreid over 24 uur. De mitochondriële functie vertoonde 
geen dag-nachtritme bij deze groep deelnemers. Bovendien was het ritme van 
genexpressie van PER2 (de negatieve terugkoppeling van de biologische klok) 
verstoord. Eveneens bleek er gedurende de 24 uur sprake te zijn van metabole 
inflexibiliteit. Deze resultaten illustreren het belang van de biologische klok 
voor het goed functioneren van het metabolisme en vergen nader onderzoek 
met interventies die erop gericht zijn het ritme te herstellen.
Het verouderingsproces gaat gepaard met een toegenomen mate van overgewicht 
en obesitas, wat op zijn beurt weer bijdraagt aan de ontwikkeling van niet-
overdraagbare ziekten. Omdat overgewicht het resultaat is van een chronische 
positieve balans tussen de inname van energie vergeleken met de gebruikte 
energie, is er meer aandacht gekomen voor het onderzoeken van methodes 
om de energiebalans weer te herstellen. Het activeren van bruin vetweefsel, 
vetweefsel dat bijzonder rijk is aan mitochondriën en energie uit voedsel kan 
omzetten in warmte (thermogenese), kan mogelijk bijdragen aan het herstellen 
van de energiebalans in de mens. Onlangs is aangetoond dat de beschikbaarheid 
van creatine in vetweefsel vergaande effecten heeft op de thermogenese en de 
energiebalans in muizen. Welk effect creatine heeft op de thermogenese en de 
energiebalans in de mens is nog onbekend. In Hoofdstuk 6 werd in 14 gezonde 
volwassen vegetariërs in een gerandomiseerde placebo-gecontroleerde studie 
het effect van creatine suppletie op de activering van het bruin vetweefsel en 
A
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op de dieet-geïnduceerde thermogenese onderzocht. Suppletie met creatine bij 
deze jonge gezonde volwassene leidt niet tot een verbeterde activering van het 
bruin vetweefsel na blootstelling aan kou. Ook neemt de dieet-geïnduceerde 
thermogenese niet toe. Deze resultaten sluiten niet uit dat creatine suppletie in 
mensen met obesitas mogelijk wel van toegevoegde waarde is voor het toenemen 
van bruin vet activatie en dieet-geïnduceerde thermogenese, dus is er aanvullend 
onderzoek nodig om deze vraag te beantwoorden.
Conclusies
Het doel van dit proefschrift was om nieuwe doelen te identificeren en te 
onderzoeken om het gezond ouder worden te bevorderen door de metabole 
gezondheid te verbeteren. Hoofdstuk 2 suggereert dat voor NAD+ suppletie 
een gecombineerde aanpak met een andere interventie vereist om het volledige 
potentieel te benutten, aangezien suppletie met NAD+-precursoren alleen de 
mitochondriele functie niet verbeterde (Hoofdstuk 3). Tevens levert Hoofdstuk 
4 duidelijk bewijs dat lichaamsbeweging op hogere leeftijd gunstig is voor het 
behoud van de algehele metabole gezondheid en fysieke prestaties.
Aangezien NAD+ betrokken is bij de aansturing van de biologische klok kan de 
afname van NAD+ met veroudering een factor zijn in het verlies van het ritme 
in de mitochondriale functie en componenten van de biologische klok zoals 
gevonden in Hoofdstuk 5. In het geval dat veroudering inderdaad bijdraagt 
aan het verlies van het 24 uurs ritme van de stofwisseling zou het interessant 
zijn om vervolgens strategieën te onderzoeken die erop gericht zijn het ritme te 
herstellen.
Hoewel er geen effecten van creatinesuppletie op bruin vet activering of door 
dieet-geïnduceerde thermogenese werden waargenomen in Hoofdstuk 6, 
moet de rol van creatine binnen de energiebalans van de mens verder worden 
onderzocht om volledig te worden opgehelderd.
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